


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:50:21Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406880" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406880</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>bmjo</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="pmc-domain-id">1609</journal-id><journal-id journal-id-type="pmc-domain">bmjo</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406880</article-id><article-id pub-id-type="pmcid-ver">PMC12406880.1</article-id><article-id pub-id-type="pmcaid">12406880</article-id><article-id pub-id-type="pmcaiid">12406880</article-id><article-id pub-id-type="pmid">40887113</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2024-098087</article-id><article-id pub-id-type="publisher-id">bmjopen-2024-098087</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Oncology</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1717</subject><subject>1506</subject></subj-group></article-categories><title-group><article-title>Patient journey and timeliness of care for patients with breast cancer in Africa: a scoping review</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kibret</surname><given-names initials="AA">Anteneh Ayelign</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8394-6077</contrib-id><name name-style="western"><surname>Jiang</surname><given-names initials="H">Heng</given-names></name><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="H">Haifeng</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0877-0424</contrib-id><name name-style="western"><surname>Liu</surname><given-names initials="C">Chaojie</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp"/></contrib><aff id="aff1"><label>1</label><institution content-type="department">Public Health</institution>, <institution>La Trobe University School of Psychology and Public Health</institution>, <addr-line content-type="city">Melbourne</addr-line>, <addr-line content-type="state">Victoria</addr-line>, <country>Australia</country></aff><aff id="aff2"><label>2</label><institution content-type="department">Human Anatomy</institution>, <institution>University of Gondar College of Medicine and Health Sciences</institution>, <addr-line content-type="city">Gondar</addr-line>, <country>Ethiopia</country></aff><aff id="aff3"><label>3</label><institution>La Trobe University School of Psychology and Public Health</institution>, <addr-line content-type="city">Melbourne</addr-line>, <addr-line content-type="state">Victoria</addr-line>, <country>Australia</country></aff><aff id="aff4"><label>4</label><institution>The University of Melbourne School of Population and Global Health</institution>, <addr-line content-type="city">Melbourne</addr-line>, <addr-line content-type="state">Victoria</addr-line>, <country>Australia</country></aff><aff id="aff5"><label>5</label><institution content-type="department">School of Information Engineering</institution>, <institution>Hubei University of Chinese Medicine Affiliated Xiangyang Hospital</institution>, <addr-line content-type="city">Xiangyang</addr-line>, <addr-line content-type="state">Hubei</addr-line>, <country>China</country></aff></contrib-group><author-notes><fn><p>Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p></fn><fn fn-type="COI-statement" id="fn4"><p>None declared.</p></fn><corresp id="cor1">Dr Chaojie Liu; <email xlink:href="c.liu@latrobe.edu.au">c.liu@latrobe.edu.au</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>31</day><month>8</month><year>2025</year></pub-date><volume>15</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">494363</issue-id><elocation-id>e098087</elocation-id><history><date date-type="received"><day>17</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>30</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>31</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:&#160;<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="bmjopen-15-8.pdf"/><self-uri xlink:title="pdf" xlink:href="bmjopen-15-8.pdf"/><abstract><sec><title> Abstract</title></sec><sec><title>Objectives</title><p>Timely access to breast cancer care is critical for improving prognosis and survival, but multiple barriers can lead to prolonged intervals across the care pathway. This scoping review aims to identify the methods used to measure timeliness in breast cancer care, pinpoint specific points in the care pathway where longer time intervals are most common and categorise the factors influencing the timeliness of care in Africa.</p></sec><sec><title>Design</title><p>Scoping review followed the methodological framework for scoping reviews outlined by Arksey and O&#8217;Malley.</p></sec><sec><title>Data sources</title><p>Five electronic databases, MEDLINE, EMBASE, CINAHL, Web of science, and PsycINFO, were searched for articles published between 1999 and 2024, and the Google search engine was used to search for grey literature.</p></sec><sec><title>Eligibility criteria for selecting studies</title><p>We included studies that measured time to presentation, diagnosis or treatment within the context of breast cancer care in Africa, and/or assessed one or more of these care intervals.</p></sec><sec><title>Data extraction and synthesis</title><p>Two reviewers independently screened relevant abstracts and full texts against the selection criteria. Key themes were then synthesised narratively based on a predefined theoretical framework adapted from the Model of Pathways to Treatment and Andersen&#8217;s model of health service.</p></sec><sec><title>Result</title><p>The initial search identified 3552 articles, with 29 studies ultimately included for data charting. All the included studies drew samples from healthcare facilities. This review identified seven multidirectional key time points: symptom onset, recognising the need for help, engaging with informal care providers, presenting at a health facility, receiving a diagnosis, consulting a specialist and starting treatment. The review also revealed significant variation in the terminology used for time events and in the metrics defining time intervals. The time interval between symptom recognition and contact with a healthcare provider was the most frequently studied and was often longer than other intervals. In many African countries, traditional healers and spiritual sites were the first point of contact for many patients with breast cancer after noticing initial symptoms. There was a scarcity of research into completion of cancer treatment and follow-up, despite significant barriers in accessing and affording cancer care.</p></sec><sec><title>Conclusion</title><p>This review highlights significant variation in how timeliness of breast cancer care are defined and measured across African countries, underscoring the need for standardised tools to assess care intervals. The predominance of facility-based studies may overlook patients who never reach formal healthcare settings, pointing to a critical gap in community-level evidence. These findings emphasise the importance of adopting a systems-based approach to improve breast cancer care, one that integrates both formal and informal care pathways and actively involves patients in navigating timely access to services.</p></sec></abstract><kwd-group><kwd>Breast tumours</kwd><kwd>Adult oncology</kwd><kwd>Africa South of the Sahara</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001215</institution-id><institution>La Trobe University</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>STRENGTHS AND LIMITATIONS OF THIS STUDY</title></caption><list list-type="bullet" list-content="ul"><list-item><p>A comprehensive search was conducted, covering both peer-reviewed and relevant grey literature.</p></list-item><list-item><p>This review used the Model of Pathways to Treatment to map time events and Andersen&#8217;s model of health service utilisation to categorise factors associated with longer time intervals in breast cancer care.</p></list-item><list-item><p>This study was guided by a previously published protocol.</p></list-item><list-item><p>Quality of the included studies was not assessed.</p></list-item><list-item><p>Only studies published in the English language were included.</p></list-item></list></boxed-text><sec sec-type="background" id="s1"><title>Background</title><p> Breast cancer is the most frequently diagnosed cancer in women and the leading cause of cancer-related deaths among female patients, which disproportionately affects women in developing countries.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> In 2022, approximately 2.3&#8201;million people were diagnosed with breast cancer, accounting for 11.6% of all global cancer cases, and 665&#8201;683 individuals died from the disease, representing 6.9% of all cancer-related deaths worldwide.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref> Developing regions, such as South America, Africa and Asia, have seen a rapid rise in both breast cancer incidence and mortality. For instance, the Global Cancer Observatory (GLOBOCAN) reported that in 2022, Africa recorded 1&#8201;98&#8201;342 cases and 91&#8201;173 deaths related to breast cancer. By contrast, Europe and North America had higher incidence rates but significantly lower mortality. For instance, Europe reported approximately 557&#8201;873 new cases and 144&#8201;510 deaths, while North America reported 3&#8201;06&#8201;198 cases and 49&#8201;727 deaths.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref></p><p>In Africa, healthcare systems face a double burden of disease, grappling with high rates of infectious diseases and maternal and child mortality, alongside a disproportionately high increase in non-communicable diseases. The prevalence of breast cancer in Africa is expected to rise as more women adopt Western reproductive and dietary habits, which have been linked to an increased risk of the disease.<xref rid="R4" ref-type="bibr"><sup>4</sup></xref> Currently, breast cancer is the most common cancer among women in Africa, with its incidence steadily rising over the past 30 years. Mortality rates remain high, and survival rates are lower across the African continent as compared with developed countries.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref> This is largely due to late-stage presentation and inadequate treatment.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref> According to Duggan <italic toggle="yes">et al</italic>,<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> studies from sub-Saharan African countries such as Ethiopia, Nigeria, Kenya and Ghana consistently report that fewer than 30% of invasive breast cancers are diagnosed at early stages (I or II), with the majority presenting at advanced stages (III or IV). In contrast, high-income countries consistently report early-stage diagnosis in more than 60% of invasive breast cancer cases. Achieving this level of early detection has been a common feature across countries with declining mortality rates, making it a clinically meaningful and reasonable goal for health systems in Africa.</p><p>Delayed presentation to health facilities after recognition of first symptoms largely contributes to advanced stage diagnosis of breast cancer.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref> In Africa, more than half (54%) of African women with breast cancer delay seeking medical care for over 3&#8201;months after symptom recognition.<xref rid="R9" ref-type="bibr"><sup>9</sup></xref> Effective cancer care relies on key components such as early diagnosis, appropriate referral and access to evidence-based treatments, such as surgery, radiotherapy and systemic therapies. Early detection greatly improves treatment outcomes; however, in low- and middle-income countries (LMICs), many cancer cases go unreported and many are diagnosed at advanced stages when the disease has become aggressive or has metastasised.<xref rid="R10" ref-type="bibr"><sup>10 11</sup></xref></p><p>The patient journey from the onset of symptoms to the completion of treatment is complex, with multiple stages that can differ greatly across various healthcare systems.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> Longer time intervals in presentation, diagnosis and treatment are major factors affecting breast cancer survival, yet they have not been comprehensively studied in Africa. The Breast Health Global Initiative has emphasised the need for downstaging interventions to promote early diagnosis and timely access to treatment in LMICs.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> Building on this, the WHO launched the Global Breast Cancer Initiative (GBCI) in 2021, which outlines a three-pillar framework for improving breast cancer outcomes globally: early detection, timely diagnosis and treatment to completion. The GBCI also introduces key performance indicators, including the recommendation that diagnosis be achieved within 60 days of symptom recognition.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref> These benchmarks are intended to support standardisation and guide national cancer control programmes. Understanding the factors influencing time intervals in breast cancer care in Africa is essential to inform such efforts and develop strategies to promote earlier diagnosis and timely treatment initiation.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> Promoting early cancer diagnosis and timely access to treatment is a critical component of any comprehensive cancer control strategy. For example, patients with breast cancer who delay treatment by more than 3&#8201;months after symptom onset have a 12% higher 5-year mortality rate compared with those treated within 3&#8201;months.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> A recent systematic review and meta-analysis of 34 studies further revealed that a cancer treatment delay of just 4&#8201;weeks is associated with an increased risk of death.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref></p><p>Adding to the complexity is the challenge of completing cancer treatment in resource-poor health systems, such as those in Africa. In Africa, longer time intervals in the diagnosis and treatment of breast cancer are often influenced by systemic challenges within the healthcare system.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> Socioeconomic barriers, such as poverty and limited awareness, hinder timely access to care.<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> The absence of universal health coverage exacerbates disparities, leaving many patients unable to afford or access essential medical services. Additionally, a shortage of healthcare workers and infrastructure further limits the capacity to provide timely and effective care. The coexistence of formal and informal care systems, with many patients consulting traditional healers or religious groups before or alongside formal healthcare, adds complexity.<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> Furthermore, the lack of integration or referral pathways between these systems contributes to delays, preventing patients from receiving timely diagnosis and treatment.</p><p>Understanding the entire patient journey of cancer care is critical for creating interventions that promote timely detection. The measurement of time interval in breast cancer care is a key indicator for enhancing strategies aimed at improving the quality of care and service delivery, as well as for developing programmes that drive change. However, studies in Africa use various metrics to measure and define different time intervals in breast cancer care, with no common standardised cut-off point.<xref rid="R21" ref-type="bibr"><sup>21 22</sup></xref> Therefore, this scoping review aims to evaluate the methods used to measure the timeliness of breast cancer care, identify specific points in the care pathway where longer time intervals are most frequently reported and examine the factors affecting the timeliness of breast cancer care in Africa. It aims to provide a well-organised summary of findings to inform decision-making for policymakers, cancer programme managers and healthcare providers.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2-1"><title>Conceptual framework</title><p>This scoping review used the Model of Pathways to Treatment to map time events, which specifies the essential events, processes and time intervals that may occur in the period prior to diagnosis and the completion of medical treatment.<xref rid="R23" ref-type="bibr"><sup>23</sup></xref> The Andersen&#8217;s model of health service utilisation was used to identify associated factors of timeliness of breast cancer care that may influence each interval.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref> New themes were also added when they did not fit into the existing frameworks.</p></sec><sec id="s2-2"><title>Study design</title><p>The design of this study was guided by Arksey and O'Malley&#8217;s scoping review methodology,<xref rid="R25" ref-type="bibr"><sup>25</sup></xref> as enhanced by Levac and colleagues and the Joanna Briggs Institute.<xref rid="R26" ref-type="bibr"><sup>26 27</sup></xref> The enhanced framework consists of five stages for conducting a scoping review: (1) formulating the research question, (2) determining relevant studies by defining inclusion and exclusion criteria, (3) searching for and selecting evidence, (4) charting the evidence and (5) collating, summarising and reporting the findings. The review adhered to the guidelines set forth by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. Detailed information about the study design has been published separately and no adjustment was made to the published protocol.<xref rid="R28" ref-type="bibr"><sup>28</sup></xref></p></sec><sec id="s2-3"><title>Data sources</title><p>The literature search was guided by the review objectives and the population, concept and content (PCC) criteria.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> The search strategy was developed with guidance from a health sciences subject librarian and applied in accordance with the Peer Review of Electronic Search Strategies guidelines. The search strategy was pretested prior to the actual search. Search terms and free-text words were combined using the Boolean operators &#8216;AND&#8217; and &#8216;OR&#8217; (full search strategy in <xref rid="ST1" ref-type="supplementary-material">online supplemental table 1</xref>).</p><p>A comprehensive literature search was conducted on the following electronic databases: MEDLINE, SCOPUS, CINAHL, Web of science, EMBASE and PsycINFO. Additionally, relevant grey literature sources were searched by using Google search engine for potentially eligible articles, such as the publication database of the WHO&#8217;s International Agency for Research on Cancer (IARC) and the Cancer Atlas of the Union for International Cancer Control (UICC). A hand-search of reference lists of included studies was conducted. All articles published up to the lastdate of search (20 June 2024) were considered, and only articles written in English were eligible.</p></sec><sec id="s2-4"><title>Eligibility criteria</title><p>Inclusion criteria were defined using the PCC framework proposed by Peters and colleagues.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> The eligible population included women with breast cancer in African contexts. The concepts of interest were different time events of breast cancer care. To be eligible for inclusion, studies needed to have measured either the time to presentation, time to diagnosis or time to treatment within the context of breast cancer care in Africa, and/or assessed one of the time intervals, regardless of whether they evaluated factors associated with these time intervals.</p><p>Articles that focused solely or primarily on men and articles published in languages other than English were excluded. Studies that focused primarily on screening asymptomatic individuals were also excluded.</p></sec><sec id="s2-5"><title>Study selection</title><p>The review process involved two levels of screening. After removing duplicate records, two reviewers (AAK and HY) independently screened the titles and abstracts of all retrieved articles using Covidence. Any articles considered relevant by either reviewer were included for full-text assessment. In the second step, the reviewers retrieved the full texts of those studies and independently evaluated them to determine whether they met the inclusion and exclusion criteria.</p><p>Disagreements in eligibility assessment were resolved through discussions between the two reviewers or further discussions with the senior authors. A Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews flow diagram (<xref rid="F1" ref-type="fig">figure 1</xref>) is presented to provide a comprehensive visual representation of the studies that were included and excluded during the process.</p><fig position="float" id="F1" fig-type="figure" orientation="portrait"><label>Figure 1</label><caption><title>Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart of the study selection process.</title></caption><graphic position="float" orientation="portrait" xlink:href="bmjopen-15-8-g001.jpg"/></fig></sec><sec id="s2-6"><title>Data extraction</title><p>The data were extracted by the lead author AAK using a data chart form and examined by authors (CL, HJ and HY). The extracted data encompassed three domains: (1) study characteristics (authors, country of the study, publication year, study design, study setting, study population and sample size), (2) time events and time intervals (definition of time intervals and guidelines, time interval indicators, metrics to measure time intervals or timeliness and findings) and (3) factors associated with time intervals (predisposing, needs, enabling and contextual factors).<xref rid="R24" ref-type="bibr"><sup>24</sup></xref> Study eligibility was reverified at the start of/during data extraction.</p></sec><sec id="s2-7"><title>Data analysis</title><p>In this scoping review, data analysis involved both quantitative and qualitative synthesis. Frequency distributions of the included studies in terms of their characteristics and key findings were calculated.</p><p>The extracted data were coded to highlight important themes in line with the existing frameworks. Time to presentation, diagnosis and treatment were analysed according to the Model of Pathways to Treatment.<xref rid="R23" ref-type="bibr"><sup>23</sup></xref> Andersen&#8217;s model of health service utilisation was used to assess factors related to the patient, healthcare providers (HCP), the health system and the disease itself that could impact the timeliness of breast cancer diagnosis.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref> Relationships between themes, populations and findings were illustrated using tables.</p><p>The quantitative and qualitative syntheses were summarised narratively to provide a clear and coherent presentation of the findings.</p></sec><sec id="s2-8"><title>Patient and public involvement</title><p>Patients or the public were not involved in this research.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3-1"><title>Search results</title><p>A total of 3552 records were identified from literature database searches: SCOPUS (n=1067), MEDLINE (n=834), Embase (n=652), Web of science (n=437), CINAHL (n=423) and PsycINFO (n=139). After removal of the duplicates (n=1714), 1838 records went through screening by titles and abstracts: 1650 were deemed ineligible. The full texts of the remaining 188 potentially eligible studies were reviewed against the predefined inclusion and exclusion criteria. This resulted in a final sample of 29 studies included in the scoping review (<xref rid="F1" ref-type="fig">figure 1</xref>).</p></sec><sec id="s3-2"><title>Characteristics of included studies</title><p><xref rid="T1" ref-type="table">Table 1</xref> describes the characteristics of included studies. The studies were published from 1999 to 2024, with the vast majority (93.1%) published after 2011. The representation of studies across African regions was uneven. East Africa accounted for the largest number of studies (11), followed by West Africa (8) and Northern Africa (7), while Southern Africa had only two studies. Additionally, one multicentre study was conducted across Nigeria, Namibia, Uganda and Zambia. Almost 90% of the studies used a cross-sectional study design to investigate delays in different time intervals (patient, diagnostic and treatment time intervals).</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><title>Characteristics of included studies (n=29)</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" rowspan="1" colspan="1">Characteristic</th><th valign="bottom" rowspan="1" colspan="1">Category</th><th valign="bottom" rowspan="1" colspan="1">N</th><th valign="bottom" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td rowspan="2" align="left" valign="top" colspan="1">Year of publication</td><td align="left" valign="top" rowspan="1" colspan="1">1999&#8211;2010</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">6.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2011&#8211;2024</td><td align="left" valign="top" rowspan="1" colspan="1">27</td><td align="left" valign="top" rowspan="1" colspan="1">93.1</td></tr><tr><td rowspan="5" align="left" valign="top" colspan="1">Study setting</td><td align="left" valign="top" rowspan="1" colspan="1">East Africa</td><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">41.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">West Africa</td><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">27.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">North Africa</td><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">20.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">South Africa</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">6.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Multi-country: Nigeria, Namibia, Uganda and Zambia</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">3.4</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">Methodological approach</td><td align="left" valign="top" rowspan="1" colspan="1">Quantitative</td><td align="left" valign="top" rowspan="1" colspan="1">24</td><td align="left" valign="top" rowspan="1" colspan="1">82.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Qualitative</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">13.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mixed methods</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">3.4</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Study design</td><td align="left" valign="top" rowspan="1" colspan="1">Cross-sectional</td><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">89.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cohort</td><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">10.3</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Sample size</td><td align="left" valign="top" rowspan="1" colspan="1">Range</td><td align="left" valign="top" rowspan="1" colspan="1">14&#8211;1429</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">All studies in total</td><td align="left" valign="top" rowspan="1" colspan="1">6764</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><p>The study participants were mostly adult women who were diagnosed with breast cancer at any stage, though one Moroccan study<xref rid="R29" ref-type="bibr"><sup>29</sup></xref> restricted participants to patients with advanced breast cancer. All studies recruited study participants from cancer care facilities. Of these, 20 (69%) used samples drawn from a single institution, while nine used samples from multiple institutions, with sample size that individual studies used ranging from 14 to 1429. No studies drew samples from the community.</p><p>Most of (24/29) articles were quantitative and one used mixed method. More than 90% of studies collected data through structured or semistructured questionnaires, typically administered by trained researchers or medical staff around the time of diagnosis, with some data extracted from medical records. However, two studies relied solely on medical records retrospectively.<xref rid="R30" ref-type="bibr"><sup>30 31</sup></xref></p><sec id="s3-2-1"><title>Time points in breast cancer care</title><p>The selected articles identify several key time points related to breast cancer, including the onset of symptoms, recognition of the need to seek help, contact with informal care providers, presentation at a health facility, diagnosis, consultation with a specialist and the start of treatment. <xref rid="T2" ref-type="table">Table 2</xref> depicts the full time point definitions.</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><title>Definitions of key time points in the breast cancer care pathway</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" rowspan="1" colspan="1">Time point</th><th valign="bottom" rowspan="1" colspan="1">Study (Author, Year)</th><th valign="bottom" rowspan="1" colspan="1">Country</th><th valign="bottom" rowspan="1" colspan="1">Definition</th></tr></thead><tbody><tr><td rowspan="17" valign="top" align="left" colspan="1">Symptom onset</td><td valign="top" align="left" rowspan="1" colspan="1">Tesfaw <italic toggle="yes">et al</italic><xref rid="R52" ref-type="bibr"><sup>52</sup></xref> (2020)</td><td valign="top" align="left" rowspan="1" colspan="1">Ethiopia</td><td rowspan="5" valign="top" align="left" colspan="1">Date of first symptom discovery</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mimouni <italic toggle="yes">et al</italic><xref rid="R31" ref-type="bibr"><sup>31</sup></xref> (2022)</td><td valign="top" align="left" rowspan="1" colspan="1">Morocco</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Maghous <italic toggle="yes">et al</italic><xref rid="R29" ref-type="bibr"><sup>29</sup></xref> (2016)</td><td valign="top" align="left" rowspan="1" colspan="1">Morocco</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Balhi <italic toggle="yes">et al</italic><xref rid="R34" ref-type="bibr"><sup>34</sup></xref> (2023)</td><td valign="top" align="left" rowspan="1" colspan="1">Tunisia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Agodirin <italic toggle="yes">et al</italic><xref rid="R33" ref-type="bibr"><sup>33</sup></xref> (2020)</td><td valign="top" align="left" rowspan="1" colspan="1">Nigeria</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R41" ref-type="bibr"><sup>41</sup></xref> (2018)</td><td valign="top" align="left" rowspan="1" colspan="1">South Africa</td><td rowspan="3" valign="top" align="left" colspan="1">Date of detection of bodily changes</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Moodley et al<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> (2016)</td><td valign="top" align="left" rowspan="1" colspan="1">South Africa</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gebremariam <italic toggle="yes">et al</italic><xref rid="R42" ref-type="bibr"><sup>42</sup></xref> (2019)</td><td valign="top" align="left" rowspan="1" colspan="1">Ethiopia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zahfir <italic toggle="yes">et al</italic><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> (2022)</td><td valign="top" align="left" rowspan="1" colspan="1">Morocco</td><td rowspan="3" valign="top" align="left" colspan="1">Date of breast symptom onset</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pace <italic toggle="yes">et al</italic><xref rid="R36" ref-type="bibr"><sup>36</sup></xref> (2015)</td><td valign="top" align="left" rowspan="1" colspan="1">Rwanda</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Daniel et al. (2023)<xref rid="R49" ref-type="bibr"><sup>49</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Kenya</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R45" ref-type="bibr"><sup>45</sup></xref> (2018)</td><td valign="top" align="left" rowspan="1" colspan="1">Mali</td><td rowspan="5" valign="top" align="left" colspan="1">The first date of recognition of the first symptom</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Foerster <italic toggle="yes">et al</italic><xref rid="R43" ref-type="bibr"><sup>43</sup></xref> (2021)</td><td valign="top" align="left" rowspan="1" colspan="1">Nigeria, Namibia, Uganda, Zambia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hassen <italic toggle="yes">et al</italic><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> (2021)</td><td valign="top" align="left" rowspan="1" colspan="1">Ethiopia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Muhammed <italic toggle="yes">et al</italic><xref rid="R40" ref-type="bibr"><sup>40</sup></xref> (2022)</td><td valign="top" align="left" rowspan="1" colspan="1">Ethiopia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R46" ref-type="bibr"><sup>46</sup></xref> (2019)</td><td valign="top" align="left" rowspan="1" colspan="1">Mali</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Jemebere<xref rid="R64" ref-type="bibr"><sup>64</sup></xref> (2019)</td><td valign="top" align="left" rowspan="1" colspan="1">Ethiopia</td><td valign="top" align="left" rowspan="1" colspan="1">Appearance of breast cancer symptoms</td></tr><tr><td rowspan="5" valign="top" align="left" colspan="1">Recognition of help need</td><td valign="top" align="left" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R41" ref-type="bibr"><sup>41</sup></xref> (2018)</td><td valign="top" align="left" rowspan="1" colspan="1">South Africa</td><td valign="top" align="left" rowspan="1" colspan="1">Date patient perceived need to discuss with HCP</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Agodirin <italic toggle="yes">et al</italic><xref rid="R33" ref-type="bibr"><sup>33</sup></xref> (2020)</td><td valign="top" align="left" rowspan="1" colspan="1">Nigeria</td><td valign="top" align="left" rowspan="1" colspan="1">Date of first disclosure</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R47" ref-type="bibr"><sup>47</sup></xref> (2018)</td><td valign="top" align="left" rowspan="1" colspan="1">Mali</td><td valign="top" align="left" rowspan="1" colspan="1">Perceiving reason to seek care</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R32" ref-type="bibr"><sup>32</sup></xref> (2016)</td><td valign="top" align="left" rowspan="1" colspan="1">South Africa</td><td valign="top" align="left" rowspan="1" colspan="1">Perceived reason to consult HCP</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Foerster <italic toggle="yes">et al</italic><xref rid="R43" ref-type="bibr"><sup>43</sup></xref> (2021)</td><td valign="top" align="left" rowspan="1" colspan="1">Nigeria,Namibia, Uganda, Zambia</td><td valign="top" align="left" rowspan="1" colspan="1">First contact with close relative/friend</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Informal care provider contact</td><td valign="top" align="left" rowspan="1" colspan="1">Foerster <italic toggle="yes">et al</italic><xref rid="R43" ref-type="bibr"><sup>43</sup></xref> (2021)</td><td valign="top" align="left" rowspan="1" colspan="1">Nigeria,Namibia, Uganda, Zambia</td><td valign="top" align="left" rowspan="1" colspan="1">Visited traditional healer or religious leader</td></tr><tr><td rowspan="16" valign="top" align="left" colspan="1">Presentation in health facility</td><td valign="top" align="left" rowspan="1" colspan="1">Tesfaw <italic toggle="yes">et al</italic><xref rid="R52" ref-type="bibr"><sup>52</sup></xref> (2020)</td><td valign="top" align="left" rowspan="1" colspan="1">Ethiopia</td><td rowspan="4" valign="top" align="left" colspan="1">Date of first HCP contact</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hassen <italic toggle="yes">et al</italic><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> (2021)</td><td valign="top" align="left" rowspan="1" colspan="1">Ethiopia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gebremariam <italic toggle="yes">et al</italic><xref rid="R42" ref-type="bibr"><sup>42</sup></xref> (2019)</td><td valign="top" align="left" rowspan="1" colspan="1">Ethiopia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Daniel <italic toggle="yes">et al</italic><xref rid="R49" ref-type="bibr"><sup>49</sup></xref> (2023)</td><td valign="top" align="left" rowspan="1" colspan="1">Kenya</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pace <italic toggle="yes">et al</italic><xref rid="R36" ref-type="bibr"><sup>36</sup></xref> (2015)</td><td valign="top" align="left" rowspan="1" colspan="1">Rwanda</td><td valign="top" align="left" rowspan="1" colspan="1">First presentation to doctor/nurse</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R45" ref-type="bibr"><sup>45</sup></xref> (2018)</td><td valign="top" align="left" rowspan="1" colspan="1">Mali</td><td rowspan="4" valign="top" align="left" colspan="1">First healthcare visit</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Agodirin <italic toggle="yes">et al</italic><xref rid="R33" ref-type="bibr"><sup>33</sup></xref> (2020)</td><td valign="top" align="left" rowspan="1" colspan="1">Nigeria</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Muhammed <italic toggle="yes">et al</italic><xref rid="R40" ref-type="bibr"><sup>40</sup></xref> (2022)</td><td valign="top" align="left" rowspan="1" colspan="1">Ethiopia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R46" ref-type="bibr"><sup>46</sup></xref> (2019)</td><td valign="top" align="left" rowspan="1" colspan="1">Mali</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mimouni <italic toggle="yes">et al</italic><xref rid="R31" ref-type="bibr"><sup>31</sup></xref> (2022)</td><td valign="top" align="left" rowspan="1" colspan="1">Morocco</td><td rowspan="7" valign="top" align="left" colspan="1">First medical consultation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Jemebere<xref rid="R64" ref-type="bibr"><sup>64</sup></xref> (2019)</td><td valign="top" align="left" rowspan="1" colspan="1">Ethiopia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Maghous <italic toggle="yes">et al</italic><xref rid="R29" ref-type="bibr"><sup>29</sup></xref> (2016)</td><td valign="top" align="left" rowspan="1" colspan="1">Morocco</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zahfir <italic toggle="yes">et al</italic><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> (2022)</td><td valign="top" align="left" rowspan="1" colspan="1">Morocco</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R32" ref-type="bibr"><sup>32</sup></xref> (2016)</td><td valign="top" align="left" rowspan="1" colspan="1">South Africa</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GrosseFri <italic toggle="yes">et al</italic><xref rid="R45" ref-type="bibr"><sup>45</sup></xref> (2018)</td><td valign="top" align="left" rowspan="1" colspan="1">Mali</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Balhi <italic toggle="yes">et al</italic><xref rid="R34" ref-type="bibr"><sup>34</sup></xref> (2023)</td><td valign="top" align="left" rowspan="1" colspan="1">Tunisia</td></tr><tr><td valign="top" align="left" rowspan="4" colspan="1">Diagnosis</td><td valign="top" align="left" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R41" ref-type="bibr"><sup>41</sup></xref> (2018)</td><td valign="top" align="left" rowspan="1" colspan="1">South Africa</td><td valign="top" align="left" rowspan="4" colspan="1">Date of clinical diagnosis</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R45" ref-type="bibr"><sup>45</sup></xref> (2018)</td><td valign="top" align="left" rowspan="1" colspan="1">Mali</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mimouni <italic toggle="yes">et al</italic><xref rid="R31" ref-type="bibr"><sup>31</sup></xref> (2022)</td><td valign="top" align="left" rowspan="1" colspan="1">Morocco</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zahfir <italic toggle="yes">et al</italic><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> (2022)</td><td valign="top" align="left" rowspan="1" colspan="1">Morocco</td></tr><tr><td valign="top" rowspan="7" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R47" ref-type="bibr"><sup>47</sup></xref> (2018)</td><td valign="top" align="left" rowspan="1" colspan="1">Mali</td><td valign="top" rowspan="4" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R32" ref-type="bibr"><sup>32</sup></xref> (2016)</td><td valign="top" align="left" rowspan="1" colspan="1">South Africa</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Balhi <italic toggle="yes">et al</italic><xref rid="R34" ref-type="bibr"><sup>34</sup></xref> (2023)</td><td valign="top" align="left" rowspan="1" colspan="1">Tunisia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Daniel <italic toggle="yes">et al</italic><xref rid="R49" ref-type="bibr"><sup>49</sup></xref> (2023)</td><td valign="top" align="left" rowspan="1" colspan="1">Kenya</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pace <italic toggle="yes">et al</italic><xref rid="R36" ref-type="bibr"><sup>36</sup></xref> (2015)</td><td valign="top" align="left" rowspan="1" colspan="1">Rwanda</td><td valign="top" align="left" rowspan="1" colspan="1">Pathology report confirming breast cancer</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gebremariam <italic toggle="yes">et al</italic><xref rid="R42" ref-type="bibr"><sup>42</sup></xref> (2019)</td><td valign="top" align="left" rowspan="1" colspan="1">Ethiopia</td><td valign="top" align="left" rowspan="1" colspan="1">Histological or cytological confirmation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R46" ref-type="bibr"><sup>46</sup></xref> (2019)</td><td valign="top" align="left" rowspan="1" colspan="1">Mali</td><td valign="top" align="left" rowspan="1" colspan="1">Receiving results at pathology department</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Specialist consultation</td><td valign="top" align="left" rowspan="1" colspan="1">Agodirin <italic toggle="yes">et al</italic><xref rid="R33" ref-type="bibr"><sup>33</sup></xref> (2020)</td><td valign="top" align="left" rowspan="1" colspan="1">Nigeria</td><td valign="top" align="left" rowspan="1" colspan="1">Arrival at specialist clinic</td></tr><tr><td rowspan="6" valign="top" align="left" colspan="1">Start of treatment</td><td valign="top" align="left" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R41" ref-type="bibr"><sup>41</sup></xref> (2018)</td><td valign="top" align="left" rowspan="1" colspan="1">South Africa</td><td rowspan="5" valign="top" align="left" colspan="1">Date of treatment initiation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R45" ref-type="bibr"><sup>45</sup></xref> (2018)</td><td valign="top" align="left" rowspan="1" colspan="1">Mali</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mimouni <italic toggle="yes">et al</italic><xref rid="R31" ref-type="bibr"><sup>31</sup></xref> (2022)</td><td valign="top" align="left" rowspan="1" colspan="1">Morocco</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zahfir <italic toggle="yes">et al</italic><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> (2022)</td><td valign="top" align="left" rowspan="1" colspan="1">Morocco</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R32" ref-type="bibr"><sup>32</sup></xref> (2016)</td><td valign="top" align="left" rowspan="1" colspan="1">South Africa</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Daniel <italic toggle="yes">et al</italic><xref rid="R49" ref-type="bibr"><sup>49</sup></xref> (2023)</td><td valign="top" align="left" rowspan="1" colspan="1">Kenya</td><td valign="top" align="left" rowspan="1" colspan="1">Start of surgery, chemo, hormone therapy, or radiotherapy</td></tr></tbody></table><table-wrap-foot><fn fn-type="abbr"><p>HCP, healthcare providers.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2-2"><title>Methods/tools used to define and for assessing time intervals of breast cancer care</title><p>The studies showed considerable variation in the use of terminologies related to time events and intervals. For example, one study separated the appraisal interval (the time between symptom detection and the recognition of the need to seek help) from the help-seeking interval (the time between symptom detection and the first consultation with a HCP).<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> Another study defined the appraisal interval as from the detection of the first symptom to its initial disclosure to family/community members (none HCP).<xref rid="R33" ref-type="bibr"><sup>33</sup></xref> However, most studies combined the appraisal and help-seeking intervals into a single interval (the time between symptom detection and the first HCP visit/consultation). While this combined interval was often labelled as &#8216;patient delay&#8217;,<xref rid="R29" ref-type="bibr">29</xref><xref rid="R39" ref-type="bibr">3134</xref> other terms were also used: help-seeking interval,<xref rid="R40" ref-type="bibr"><sup>40</sup></xref> patient (-related) interval,<xref rid="R41" ref-type="bibr"><sup>41 42</sup></xref> precontact time,<xref rid="R43" ref-type="bibr"><sup>43</sup></xref> consultation time,<xref rid="R44" ref-type="bibr"><sup>44</sup></xref> time to first healthcare visit,<xref rid="R45" ref-type="bibr"><sup>45</sup></xref> time to presentation and delayed presentation.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> Besides, there were marked differences in how the intervals were named. For example, health-seeking interval<xref rid="R33" ref-type="bibr"><sup>33 46</sup></xref> and patient interval<xref rid="R41" ref-type="bibr"><sup>41</sup></xref> express the same time interval (time between symptom detection and first contact with healthcare provider). However, two studies defined health seeking interval as time between perceiving reasons to seek help and presentation to the first HCP.<xref rid="R32" ref-type="bibr"><sup>32 47</sup></xref></p><p>Similarly, different terminologies were used across studies to refer to the time between the first HCP visit and the date of diagnosis. Most studies used diagnostic interval,<xref rid="R32" ref-type="bibr"><sup>32 41 42 46</sup></xref> diagnostic delay<xref rid="R31" ref-type="bibr"><sup>31 35 38</sup></xref> or health system/provider delay.<xref rid="R34" ref-type="bibr"><sup>34 36</sup></xref> Other terms included time to diagnosis,<xref rid="R45" ref-type="bibr"><sup>45</sup></xref> diagnostic time,<xref rid="R33" ref-type="bibr"><sup>33 48</sup></xref> primary care interval and postcontact interval.<xref rid="R43" ref-type="bibr"><sup>43</sup></xref> The diagnostic interval was defined in various ways across studies: most commonly, it was defined as the time between the first HCP visit and diagnosis or from the presentation at a health facility to diagnosis.<xref rid="R29" ref-type="bibr"><sup>29 35 36 38 42 45</sup></xref> Terms like diagnostic delay and health system delay are often used interchangeably to refer to the time between the first HCP contact and diagnosis.<xref rid="R38" ref-type="bibr"><sup>38 45</sup></xref> However, two studies define health system delay as the interval between first contact with HCP to initiation of treatment<xref rid="R29" ref-type="bibr"><sup>29 34</sup></xref> and one study between the date of histological diagnosis and initiation of treatment.<xref rid="R35" ref-type="bibr"><sup>35</sup></xref></p><p>The time intervals from diagnosis to initiation of treatment were also named differently across studies, with terms such as pre-treatment interval,<xref rid="R41" ref-type="bibr"><sup>41</sup></xref> time to treatment,<xref rid="R45" ref-type="bibr"><sup>45</sup></xref> treatment delay,<xref rid="R31" ref-type="bibr"><sup>31</sup></xref> time to initial intervention,<xref rid="R49" ref-type="bibr"><sup>49</sup></xref> health system delay<xref rid="R35" ref-type="bibr"><sup>35</sup></xref> and delayed treatment.<xref rid="R50" ref-type="bibr"><sup>50</sup></xref></p><p>The included studies had limitations with unclear definitions of time intervals or timeliness and inconsistent methods for determining the lengths of these time intervals. Ten (34.5%) studies relied on the authors&#8217; definitions of time intervals,<xref rid="R35" ref-type="bibr">3538 45 48</xref><xref rid="R51" ref-type="bibr">51</xref> 31.0% of the studies (n=9)<xref rid="R29" ref-type="bibr">29</xref><xref rid="R53" ref-type="bibr">3136 37 52 53</xref> adopted definitions from prvious studies.<xref rid="R54" ref-type="bibr">54</xref><xref rid="R63" ref-type="bibr">63</xref> Four (13.7%) studies used the Model of Pathways to Treatment, which focuses on events of patient journey from recognising symptoms to accessing healthcare and beginning treatment.<xref rid="R32" ref-type="bibr"><sup>32 41 46 47</sup></xref> Five (17.2%) followed the Aarhus Statement: focusing on identifying intervals between symptom recognition, healthcare contact, diagnosis and treatment initiation<xref rid="R22" ref-type="bibr"><sup>22 33 40 42</sup></xref> and one (3.4%) study adopted the five stages (appraisal, illness, behavioural, schedulingand treatment) from the Andersen Model.<xref rid="R39" ref-type="bibr"><sup>39</sup></xref></p><p>The cut-off points or metrics used to define prolonged time intervals varied significantly across studies. This variation is largely due to the lack of standardised guidelines or policy statements that establish a common benchmark for measuring the length of time intervals at each stage of breast cancer care. For example, the majority considered longer time intervals between time from symptom recognition and contact with the first HCP when the interval between the recognition of symptoms and the initial medical consultation exceeded 3&#8201;months. Notably, nearly half of the studies classified longer time intervals as 3&#8201;months or more,<xref rid="R29" ref-type="bibr">29</xref><xref rid="R64" ref-type="bibr">3134 37</xref> while others set the delay at longer than 6&#8201;months,<xref rid="R36" ref-type="bibr"><sup>36 49</sup></xref> 1&#8201;month<xref rid="R35" ref-type="bibr"><sup>35</sup></xref> or 1&#8201;week.<xref rid="R29" ref-type="bibr"><sup>29</sup></xref></p><p>Similarly, the interval between first contact with HCP to diagnosis was considered a longer time interval if it exceeded 1&#8201;month in four studies,<xref rid="R33" ref-type="bibr"><sup>33 34 42 65</sup></xref> while other studies used cut-off points of 16 days,<xref rid="R35" ref-type="bibr"><sup>35</sup></xref> 2&#8201;months,<xref rid="R38" ref-type="bibr"><sup>38</sup></xref> 3&#8201;months<xref rid="R29" ref-type="bibr"><sup>29 31</sup></xref> or 6&#8201;months.<xref rid="R36" ref-type="bibr"><sup>36</sup></xref></p><p>Moreover, the interval between diagnosis to the start of treatment was also evaluated. One study considered a long time interval if this interval exceeded 48 days<xref rid="R35" ref-type="bibr"><sup>35</sup></xref> while another defined it as more than 1&#8201;month.<xref rid="R50" ref-type="bibr"><sup>50</sup></xref> Other studies classified the duration from symptom detection to treatment initiation as a long-time interval if it was 3&#8201;months or longer<xref rid="R53" ref-type="bibr"><sup>53</sup></xref> (<xref rid="ST2" ref-type="supplementary-material">online supplemental table 2</xref>).</p></sec><sec id="s3-2-3"><title>Breast cancer care intervals</title><p>22 studies (75.9%) reported on the interval from symptom recognition to the first HCP visit. Fourteen studies (48.3%) examined the interval from first HCP contact to diagnosis, four studies (13.8%) assessed the time from symptom recognition to diagnosis, six studies (20.7%) investigated the interval from diagnosis to treatment initiation and two studies (6.9%) reported on the full interval from symptom detection to treatment initiation (<xref rid="F2" ref-type="fig">figure 2</xref>). The interval &#8216;diagnosis to specialist consultation&#8217; was rarely studied. The time from initial symptom recognition to first contact with HCP was commonly studied in breast cancer research in Africa because it often represented one of the longest and most impactful delays in the care pathway.<xref rid="R66" ref-type="bibr"><sup>66</sup></xref> Only one study assessed appraisal interval (between the recognition of breast symptoms to first disclosure, eg, to partners, family and friends) and help-seeking interval (between symptom recognition and first HCP visit) as separate intervals.<xref rid="R33" ref-type="bibr"><sup>33</sup></xref></p><fig position="float" id="F2" fig-type="figure" orientation="portrait"><label>Figure 2</label><caption><title>Time intervals and median durations in the breast cancer care pathway in Africa.</title></caption><graphic position="float" orientation="portrait" xlink:href="bmjopen-15-8-g002.jpg"/></fig></sec><sec id="s3-2-4"><title>Symptom recognition to contact with first HCP</title><p>Overall, the time from symptom recognition to contact with first HCP varied widely across the African continent and even within individual countries. North African studies generally reported a shorter time interval with median estimates ranging from 1&#8201;week to 24 weeks in Morocco,<xref rid="R29" ref-type="bibr"><sup>29 35</sup></xref> 4 weeks in Tunisia<xref rid="R34" ref-type="bibr"><sup>34</sup></xref> and 5 weeks in Egypt.<xref rid="R65" ref-type="bibr"><sup>65</sup></xref></p><p>In sub-Saharan Africa, this time interval was generally longer, ranging from 1&#8201;week among non-Black groups in Namibia to 52 weeks in Uganda. Median estimates of this time interval included 3&#8211;4 weeks in South Africa, Zambia and Ethiopia, 5 weeks among Namibia&#8217;s Black population,<xref rid="R43" ref-type="bibr"><sup>43</sup></xref> 13&#8211;16 weeks in Kenya, Uganda, Libya, Nigeria and Ethiopia,<xref rid="R22" ref-type="bibr"><sup>22 43 48 49</sup></xref> and 19 weeks in Mali and Rwanda.<xref rid="R36" ref-type="bibr"><sup>36 45</sup></xref> Uganda and Ghana reported the longest time interval, at 48&#8211;52 weeks.<xref rid="R30" ref-type="bibr"><sup>30 37 67</sup></xref> This variation might be due to differences in healthcare infrastructure, socioeconomic conditions, cultural attitudes and public health systems. North African countries, such as Morocco and Egypt, often have a more mature healthcare system and better access to medical facilities than many sub-Saharan African countries.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref></p><p>Ethiopia, Uganda and Morocco showed significant variability in this interval, highlighting heterogeneity within individual countries.</p></sec><sec id="s3-2-5"><title>Contact with first HCP to diagnosis</title><p>Nearly half of the studies reported the time interval from contact with the first HCP to diagnosis. In North Africa, this interval was relatively shorter, with median estimates ranging from 1&#8201;week in Egypt to 17 weeks in Tunisia,<xref rid="R29" ref-type="bibr"><sup>29 31 34 65</sup></xref> while Sub-Saharan Africa reported longer duration in this time interval, with median estimates ranging from 3 weeks in Mali to 20 weeks in Rwanda.<xref rid="R32" ref-type="bibr"><sup>32 36 42 46</sup></xref> South Africa (4&#8211;13 weeks) and Morocco (2&#8211;14 weeks) showed notable variability in this interval, highlighting heterogeneity within each country.</p></sec><sec id="s3-2-6"><title>Symptom recognition to diagnosis</title><p>Only a few studies assessed the time interval from symptom recognition to diagnosis. The median interval ranged from 30 weeks in Libya,<xref rid="R48" ref-type="bibr"><sup>48</sup></xref> 34 weeks in Nigeria<xref rid="R33" ref-type="bibr"><sup>33</sup></xref> and 36 weeks in South Africa,<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> to 60 weeks in Rwanda.<xref rid="R36" ref-type="bibr"><sup>36</sup></xref> One multicounty study reported this time interval for Namibia (10 weeks in non-Black women and 26 weeks in Black women), Nigeria (22 weeks), Uganda (45 weeks) and Zambia (33 weeks).<xref rid="R43" ref-type="bibr"><sup>43</sup></xref></p></sec><sec id="s3-2-7"><title>Diagnosis to initiation of treatment</title><p>The median interval from diagnosis to initiation of treatment ranged from 5 weeks in South Africa and Mali,<xref rid="R41" ref-type="bibr"><sup>41 45</sup></xref> 6 weeks in Morocco and Kenya<xref rid="R31" ref-type="bibr"><sup>31 49</sup></xref> and 7 weeks in Morocco,<xref rid="R35" ref-type="bibr"><sup>35</sup></xref> to 12 weeks in Ethiopia.<xref rid="R53" ref-type="bibr"><sup>53</sup></xref> The time interval from symptom recognition to treatment was reported as 16 weeks in South Africa and 36 weeks in Nigeria<xref rid="R41" ref-type="bibr"><sup>41 50</sup></xref> (<xref rid="T3" ref-type="table">table 3</xref>).</p><table-wrap position="float" id="T3" orientation="portrait"><label>Table 3</label><caption><title>Median time intervals from symptom recognition to presentation, diagnosis and treatment reported in the studies from Africa</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" rowspan="1" colspan="1">Interval</th><th valign="bottom" rowspan="1" colspan="1">Author (Year)</th><th valign="bottom" rowspan="1" colspan="1">Country</th><th valign="bottom" rowspan="1" colspan="1">Mean (weeks)</th><th valign="bottom" rowspan="1" colspan="1">Median (IQR) (weeks)</th></tr></thead><tbody><tr><td rowspan="25" align="left" valign="top" colspan="1">Symptom recognition to First HCP contact</td><td align="left" valign="top" rowspan="1" colspan="1">Tesfaw <italic toggle="yes">et al</italic><xref rid="R52" ref-type="bibr"><sup>52</sup></xref> (2020)</td><td align="left" valign="top" rowspan="1" colspan="1">Ethiopia</td><td align="left" valign="top" rowspan="1" colspan="1">32</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R41" ref-type="bibr"><sup>41</sup></xref> (2018)</td><td align="left" valign="top" rowspan="1" colspan="1">South Africa</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">3.2 (0.8&#8211;9.1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pace <italic toggle="yes">et al</italic><xref rid="R36" ref-type="bibr"><sup>36</sup></xref> (2015)</td><td align="left" valign="top" rowspan="1" colspan="1">Rwanda</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">20 (4&#8211;52)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R45" ref-type="bibr"><sup>45</sup></xref> (2018)</td><td align="left" valign="top" rowspan="1" colspan="1">Mali</td><td align="left" valign="top" rowspan="1" colspan="1">46</td><td align="left" valign="top" rowspan="1" colspan="1">19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Salih <italic toggle="yes">et al</italic><xref rid="R39" ref-type="bibr"><sup>39</sup></xref> (2016)</td><td align="left" valign="top" rowspan="1" colspan="1">Sudan</td><td align="left" valign="top" rowspan="1" colspan="1">4.74 (45)</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Abdel-Fattah<xref rid="R65" ref-type="bibr"><sup>65</sup></xref> (1999)</td><td align="left" valign="top" rowspan="1" colspan="1">Egypt</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Galukande <italic toggle="yes">et al</italic><xref rid="R30" ref-type="bibr"><sup>30</sup></xref> (2014)</td><td align="left" valign="top" rowspan="1" colspan="1">Uganda</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">48</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Odongo <italic toggle="yes">et al</italic><xref rid="R37" ref-type="bibr"><sup>37</sup></xref> (2015)</td><td align="left" valign="top" rowspan="1" colspan="1">Uganda</td><td align="left" valign="top" rowspan="1" colspan="1">90 (104)</td><td align="left" valign="top" rowspan="1" colspan="1">52</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hassen <italic toggle="yes">et al</italic><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> (2021)</td><td align="left" valign="top" rowspan="1" colspan="1">Ethiopia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">16</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Agodirin <italic toggle="yes">et al</italic><xref rid="R33" ref-type="bibr"><sup>33</sup></xref> (2020)</td><td align="left" valign="top" rowspan="1" colspan="1">Nigeria</td><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">6 (1&#8211;21.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mimouni <italic toggle="yes">et al</italic><xref rid="R31" ref-type="bibr"><sup>31</sup></xref> (2022)</td><td align="left" valign="top" rowspan="1" colspan="1">Morocco</td><td align="left" valign="top" rowspan="1" colspan="1">1 (0.8)</td><td align="left" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zahfir <italic toggle="yes">et al</italic><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> (2022)</td><td align="left" valign="top" rowspan="1" colspan="1">Morocco</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">5 (1&#8211;25.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Maghous <italic toggle="yes">et al</italic><xref rid="R29" ref-type="bibr"><sup>29</sup></xref> (2016)</td><td align="left" valign="top" rowspan="1" colspan="1">Morocco</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">24 (16&#8211;48)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gebremariam <italic toggle="yes">et al</italic><xref rid="R42" ref-type="bibr"><sup>42</sup></xref> (2019)</td><td align="left" valign="top" rowspan="1" colspan="1">Ethiopia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">4 (0.8&#8211;18.8)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Muhammed <italic toggle="yes">et al</italic><xref rid="R84" ref-type="bibr"><sup>84</sup></xref> (2022)</td><td align="left" valign="top" rowspan="1" colspan="1">Ethiopia</td><td align="left" valign="top" rowspan="1" colspan="1">22</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R32" ref-type="bibr"><sup>32</sup></xref> (2016)</td><td align="left" valign="top" rowspan="1" colspan="1">South Africa</td><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Balhi <italic toggle="yes">et al</italic><xref rid="R34" ref-type="bibr"><sup>34</sup></xref> (2023)</td><td align="left" valign="top" rowspan="1" colspan="1">Tunisia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">4 (11.8&#8211;21.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Daniel <italic toggle="yes">et al</italic><xref rid="R49" ref-type="bibr"><sup>49</sup></xref> (2023)</td><td align="left" valign="top" rowspan="1" colspan="1">Kenya</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">13 (3&#8211;36)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Martei <italic toggle="yes">et al</italic><xref rid="R67" ref-type="bibr"><sup>67</sup></xref> (2018)</td><td align="left" valign="top" rowspan="1" colspan="1">Ghana</td><td align="left" valign="top" rowspan="1" colspan="1">62.4</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Eramah <italic toggle="yes">et al</italic><xref rid="R48" ref-type="bibr"><sup>48</sup></xref> (2012)</td><td align="left" valign="top" rowspan="1" colspan="1">Libya</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">16</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">Foerster <italic toggle="yes">et al</italic><xref rid="R43" ref-type="bibr"><sup>43</sup></xref> (2021)</td><td align="left" valign="top" rowspan="1" colspan="1">Namibia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">5 (0.8&#8211;2.48) for Black women / 1 (0.0&#8211;8.4) for non-Black</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nigeria</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">15 (4&#8211;32.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Uganda</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">14 (4&#8211;39.6)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zambia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">4 (0.8&#8211;36.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Darre <italic toggle="yes">et al</italic><xref rid="R44" ref-type="bibr"><sup>44</sup></xref> (2023)</td><td align="left" valign="top" rowspan="1" colspan="1">Togo</td><td align="left" valign="top" rowspan="1" colspan="1">24 (46.1)</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td></tr><tr><td rowspan="17" align="left" valign="top" colspan="1">First HCP contact to diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R41" ref-type="bibr"><sup>41</sup></xref> (2018)</td><td align="left" valign="top" rowspan="1" colspan="1">South Africa</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">4 (1.8&#8211;8.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pace <italic toggle="yes">et al</italic><xref rid="R36" ref-type="bibr"><sup>36</sup></xref> (2015)</td><td align="left" valign="top" rowspan="1" colspan="1">Rwanda</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">20 (8&#8211;56)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R45" ref-type="bibr"><sup>45</sup></xref> (2018)</td><td align="left" valign="top" rowspan="1" colspan="1">Mali</td><td align="left" valign="top" rowspan="1" colspan="1">25.6</td><td align="left" valign="top" rowspan="1" colspan="1">4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Abdel-Fattah <italic toggle="yes">et al</italic><xref rid="R65" ref-type="bibr"><sup>65</sup></xref> (1999)</td><td align="left" valign="top" rowspan="1" colspan="1">Egypt</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Agodirin <italic toggle="yes">et al</italic><xref rid="R33" ref-type="bibr"><sup>33</sup></xref> (2020)</td><td align="left" valign="top" rowspan="1" colspan="1">Nigeria</td><td align="left" valign="top" rowspan="1" colspan="1">36.5</td><td align="left" valign="top" rowspan="1" colspan="1">15 (2&#8211;48)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mimouni <italic toggle="yes">et al</italic><xref rid="R31" ref-type="bibr"><sup>31</sup></xref> (2022)</td><td align="left" valign="top" rowspan="1" colspan="1">Morocco</td><td align="left" valign="top" rowspan="1" colspan="1">25.4 (48.1)</td><td align="left" valign="top" rowspan="1" colspan="1">14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zahfir <italic toggle="yes">et al</italic><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> (2022)</td><td align="left" valign="top" rowspan="1" colspan="1">Morocco</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">2 (0.7&#8211;6.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Maghous <italic toggle="yes">et al</italic><xref rid="R29" ref-type="bibr"><sup>29</sup></xref> (2016)</td><td align="left" valign="top" rowspan="1" colspan="1">Morocco</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">4 (4&#8211;12)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gebremariam <italic toggle="yes">et al</italic><xref rid="R42" ref-type="bibr"><sup>42</sup></xref> (2019)</td><td align="left" valign="top" rowspan="1" colspan="1">Ethiopia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">10 (3.1&#8211;30.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R32" ref-type="bibr"><sup>32</sup></xref> (2016)</td><td align="left" valign="top" rowspan="1" colspan="1">South Africa</td><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Balhi <italic toggle="yes">et al</italic><xref rid="R34" ref-type="bibr"><sup>34</sup></xref> (2023)</td><td align="left" valign="top" rowspan="1" colspan="1">Tunisia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">7.5 (4.7&#8211;12.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Daniel <italic toggle="yes">et al</italic><xref rid="R49" ref-type="bibr"><sup>49</sup></xref> (2023)</td><td align="left" valign="top" rowspan="1" colspan="1">Kenya</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">17.5 (7&#8211;36.5)</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">Foerster <italic toggle="yes">et al</italic><xref rid="R43" ref-type="bibr"><sup>43</sup></xref> (2021)</td><td align="left" valign="top" rowspan="1" colspan="1">Namibia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">8 (2&#8211;28) for Black women / 3 (0.8&#8211;8) for non-Black</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nigeria</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">1 (0.0&#8211;12)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Uganda</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">19 (5.2&#8211;47.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zambia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">10 (4.4&#8211;39)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Darre <italic toggle="yes">et al</italic><xref rid="R44" ref-type="bibr"><sup>44</sup></xref> (2023)</td><td align="left" valign="top" rowspan="1" colspan="1">Togo</td><td align="left" valign="top" rowspan="1" colspan="1">22.8</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td></tr><tr><td rowspan="9" align="left" valign="top" colspan="1">Symptom recognition to diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R32" ref-type="bibr"><sup>32</sup></xref> (2016)</td><td align="left" valign="top" rowspan="1" colspan="1">South Africa</td><td align="left" valign="top" rowspan="1" colspan="1">36.6</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Eramah <italic toggle="yes">et al</italic><xref rid="R48" ref-type="bibr"><sup>48</sup></xref> (2012)</td><td align="left" valign="top" rowspan="1" colspan="1">Libya</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">30</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pace <italic toggle="yes">et al</italic><xref rid="R36" ref-type="bibr"><sup>36</sup></xref> (2015)</td><td align="left" valign="top" rowspan="1" colspan="1">Rwanda</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">60 (32&#8211;128)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Agodirin <italic toggle="yes">et al</italic><xref rid="R33" ref-type="bibr"><sup>33</sup></xref> (2020)</td><td align="left" valign="top" rowspan="1" colspan="1">Nigeria</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">34 (12.9&#8211;52.4)</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">Foerster <italic toggle="yes">et al</italic><xref rid="R43" ref-type="bibr"><sup>43</sup></xref> (2021)</td><td align="left" valign="top" rowspan="1" colspan="1">Namibia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">26 (9.2&#8211;62.8) for Black women / 10 (2.4&#8211;22) for non-Black</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nigeria</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">22 (9.2&#8211;52.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Uganda</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">45 (22.8&#8211;84.8)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zambia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">33 (13.6&#8211;65.6)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Darre <italic toggle="yes">et al</italic><xref rid="R44" ref-type="bibr"><sup>44</sup></xref> (2023)</td><td align="left" valign="top" rowspan="1" colspan="1">Togo</td><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td></tr><tr><td rowspan="6" align="left" valign="top" colspan="1">Diagnosis to treatment initiation</td><td align="left" valign="top" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R41" ref-type="bibr"><sup>41</sup></xref> (2018)</td><td align="left" valign="top" rowspan="1" colspan="1">South Africa</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">5 (2.5&#8211;7.1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GrosseFrie <italic toggle="yes">et al</italic><xref rid="R45" ref-type="bibr"><sup>45</sup></xref> (2018)</td><td align="left" valign="top" rowspan="1" colspan="1">Mali</td><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mimouni <italic toggle="yes">et al</italic><xref rid="R31" ref-type="bibr"><sup>31</sup></xref> (2022)</td><td align="left" valign="top" rowspan="1" colspan="1">Morocco</td><td align="left" valign="top" rowspan="1" colspan="1">38.2 (9.2)</td><td align="left" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zahfir <italic toggle="yes">et al</italic><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> (2022)</td><td align="left" valign="top" rowspan="1" colspan="1">Morocco</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">7 (4.1&#8211;9.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Daniel <italic toggle="yes">et al</italic><xref rid="R49" ref-type="bibr"><sup>49</sup></xref> (2023)</td><td align="left" valign="top" rowspan="1" colspan="1">Kenya</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">6 (3&#8211;13)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Teshome <italic toggle="yes">et al</italic><xref rid="R53" ref-type="bibr"><sup>53</sup></xref> (2021)</td><td align="left" valign="top" rowspan="1" colspan="1">Ethiopia</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">12</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Symptom recognition to treatment initiation</td><td align="left" valign="top" rowspan="1" colspan="1">Moodley <italic toggle="yes">et al</italic><xref rid="R41" ref-type="bibr"><sup>41</sup></xref> (2018)</td><td align="left" valign="top" rowspan="1" colspan="1">South Africa</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">16 (9.5&#8211;25.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ukwenya <italic toggle="yes">et al</italic><xref rid="R50" ref-type="bibr"><sup>50</sup></xref> (2008)</td><td align="left" valign="top" rowspan="1" colspan="1">Nigeria</td><td align="left" valign="top" rowspan="1" colspan="1">N/R</td><td align="left" valign="top" rowspan="1" colspan="1">36</td></tr></tbody></table><table-wrap-foot><fn fn-type="abbr"><p>HCP, healthcare providers; N/R, not reported.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2-8"><title>Where patient go after symptom recognition?</title><p>More than 90% of the included studies reported that breast lump was reported as the initial breast cancer symptom, and disclosure to family often triggered the patient to seek healthcare in most studies. In 37.5% of the studies, 27% to 90.7% of patients with breast cancer underestimated the seriousness of their symptoms.<xref rid="R22" ref-type="bibr"><sup>22 41 48</sup></xref> This was often due to limited knowledge about breast cancer symptoms and risks, limited healthcare access and cultural beliefs, and fear of stigma, which may prevent women from acknowledging or reporting breast abnormalities earlier.</p><p>In Africa, the path a patient took after detecting breast cancer symptoms varied significantly based on their specific circumstances, including their location, available resources and personal decisions. Patients with breast cancer in African countries tended to seek different first points of contact after detecting their initial symptoms, with traditional healers and spiritual places being the most common, particularly in Ethiopia (77.1%, 52.7%, 33.3%),<xref rid="R22" ref-type="bibr"><sup>22 40 52</sup></xref> Uganda (50%),<xref rid="R37" ref-type="bibr"><sup>37</sup></xref> Nigeria (50%, 45%)<xref rid="R38" ref-type="bibr"><sup>38 50</sup></xref> and Mali (35%, 24.2%).<xref rid="R45" ref-type="bibr"><sup>45 46</sup></xref> The next most common contact was tertiary hospitals, as seen in Rwanda (76%),<xref rid="R36" ref-type="bibr"><sup>36</sup></xref> Mali (50%, 45%),<xref rid="R45" ref-type="bibr"><sup>45 46</sup></xref> Ethiopia 23.3%<xref rid="R42" ref-type="bibr"><sup>42</sup></xref> and in the multicentre study across Namibia, Nigeria, Uganda and Zambia (61.6%).<xref rid="R43" ref-type="bibr"><sup>43</sup></xref> Following this, district hospitals were a frequent first choice, especially in South Africa (72%),<xref rid="R41" ref-type="bibr"><sup>41</sup></xref> Nigeria (75%)<xref rid="R33" ref-type="bibr"><sup>33</sup></xref> and Egypt (42%).<xref rid="R65" ref-type="bibr"><sup>65</sup></xref></p><p>Private clinics and community health centres were also the first point of contact, although private clinics were commonly used, especially in South Africa (22%),<xref rid="R41" ref-type="bibr"><sup>41</sup></xref> Egypt (35.4%)<xref rid="R65" ref-type="bibr"><sup>65</sup></xref> and Ethiopia (40.5%).<xref rid="R42" ref-type="bibr"><sup>42</sup></xref> Community health centres were also used in Ethiopia (54.4%, 36%)<xref rid="R22" ref-type="bibr"><sup>22 42</sup></xref> and Mali (20%).<xref rid="R45" ref-type="bibr"><sup>45</sup></xref></p><p>The breast cancer care journey in Africa was complex and marked by long-time intervals, non-linear progression, and sociocultural and economic challenges (<xref rid="F3" ref-type="fig">figure 3</xref>). After cancer diagnosis, which typically occurred at higher-level hospitals due to limited diagnostic facilities in lower-level centres, poorly structured follow-up care and limited access to primary healthcare services led many to bypass community centres for tertiary hospitals. Financial barriers, fear and cultural beliefs delayed or disrupted treatment, with many patients returning to self-care or informal care providers. One study in Ethiopia showed that 34% of breast cancer patients visited a traditional healer between diagnosis and treatment initiation.<xref rid="R53" ref-type="bibr"><sup>53</sup></xref></p><fig position="float" id="F3" fig-type="figure" orientation="portrait"><label>Figure 3</label><caption><title>Breast cancer care pathway in Africa. FNAC, fine needle aspiration cytology; GP, general practitioner.</title></caption><graphic position="float" orientation="portrait" xlink:href="bmjopen-15-8-g003.jpg"/></fig></sec></sec><sec id="s3-3"><title>Factors studied related to timeliness of breast cancer care in Africa</title><p>Factors related to timeliness of breast cancer care were identified based on the Andersen's model of health service utilisation. This framework categorises predictors into predisposing, enabling, need and contextual factors to provide a clearer understanding of the barriers influencing patient, diagnostic and treatment time interval in healthcare utilisation.</p><sec id="s3-3-1"><title>Factors influencing the time interval between symptom recognition and first HCP contact</title><p>Almost all studies examined age and educational status as an independent variable and only 10 (34.4%) investigated residence as a predictor of longer duration in this time interval. Age was the most investigated predictor of longer duration in this interval, but only three studies from South Africa, Ethiopia and Nigeria identified it as statistically significant. Low educational status and rural residence were also significant predictors in a few studies. About 41% of the studies investigated contact with traditional healers as a predictor, and three studies linked visits to traditional healers to longer durations in this interval. Knowledge and practice of breast self-examination were evaluated in 32% of the studies, with four showing an association with prolonged duration in this time interval. Factors such as long travel distances, financial constraints and clinical factors, such as painless symptoms or misperceived symptoms, were also associated with longer duration in this time interval. Family history of breast cancer was less frequently significant, despite being examined in half of the studies.</p></sec><sec id="s3-3-2"><title>Factors associated with the time interval between first HCP contact and diagnosis</title><p>Age and education were examined by 90% of the studies, with most reporting them as significant predictors, while occupation was examined in over half of the studies. One quarter of the studies examined failure to perform breast self-examination and two studies linked it to longer duration in this time interval. Other factors, including the type of HCP first seen, multiple facility visits, travel time and distance to health facilities, and the type of first consultation, were also associated with this time interval. A few studies highlighted the absence of a palpable lump and fear of diagnosis as predictors of longer duration in this time interval.</p></sec><sec id="s3-3-3"><title>Factors contributing to the time interval between diagnosis and treatment initiation</title><p>Age, cancer stage, financial constraints and histological nodal status were associated with this time interval (<xref rid="T4" ref-type="table">table 4</xref>).</p><table-wrap position="float" id="T4" orientation="portrait"><label>Table 4</label><caption><title>Factors contributing to time intervals in breast cancer care in Africa.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" rowspan="1" colspan="1">Interval</th><th valign="bottom" rowspan="1" colspan="1">Category</th><th valign="bottom" rowspan="1" colspan="1">Factor</th><th valign="bottom" rowspan="1" colspan="1">Key findings</th></tr></thead><tbody><tr><td rowspan="10" align="left" valign="top" colspan="1">Symptom recognition to first HCP contact</td><td rowspan="2" align="left" valign="top" colspan="1">Predisposing</td><td align="left" valign="top" rowspan="1" colspan="1">Age<xref rid="R22" ref-type="bibr"><sup>22 38 41</sup></xref></td><td align="left" valign="top" rowspan="1" colspan="1">Older age linked to longer time intervals (up to 4.8&#8201;x)<xref rid="R22" ref-type="bibr"><sup>22</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education<xref rid="R22" ref-type="bibr"><sup>22 33 52</sup></xref></td><td align="left" valign="top" rowspan="1" colspan="1">Low education linked to 3.8&#8211;13&#8201;x longer intervals</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Enabling</td><td align="left" valign="top" rowspan="1" colspan="1">Traditional healer visits before formal HCP<xref rid="R36" ref-type="bibr"><sup>36 42 84</sup></xref></td><td align="left" valign="top" rowspan="1" colspan="1">2.13&#8211;4.2&#8201;x longer; avoiding reduces risk by 85%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Financial barriers</td><td align="left" valign="top" rowspan="1" colspan="1">Linked to prolonged intervals<xref rid="R39" ref-type="bibr"><sup>39 67</sup></xref></td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">Need</td><td align="left" valign="top" rowspan="1" colspan="1">Symptom perception</td><td align="left" valign="top" rowspan="1" colspan="1">Painless or no armpit lump=3.3&#8211;9&#8201;x longer; Recognising symptoms as cancer reduces delay (AOR=0.2)<xref rid="R22" ref-type="bibr"><sup>22 52</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Myths/fear</td><td align="left" valign="top" rowspan="1" colspan="1">Fear of mastectomy, denial, misconceptions linked to delays</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Family history</td><td align="left" valign="top" rowspan="1" colspan="1">No family history of breast cancer=2.4&#8211;5.1&#8201;x longer<xref rid="R52" ref-type="bibr"><sup>52 84</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Breast self-exam</td><td align="left" valign="top" rowspan="1" colspan="1">Poor knowledge/practice linked to longer delays<xref rid="R34" ref-type="bibr"><sup>34 39 45 64</sup></xref></td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Contextual</td><td align="left" valign="top" rowspan="1" colspan="1">Residence</td><td align="left" valign="top" rowspan="1" colspan="1">Rural=3.7&#8201;x longer; urban=58&#8211;79%&#8201;shorter<xref rid="R22" ref-type="bibr"><sup>22 36 52</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Facility access</td><td align="left" valign="top" rowspan="1" colspan="1">&#8805;5&#8201;km travel=1.3&#8211;3&#8201;x longer intervals<xref rid="R52" ref-type="bibr"><sup>52 84</sup></xref></td></tr><tr><td rowspan="10" align="left" valign="top" colspan="1">First HCP contact to diagnosis</td><td rowspan="3" align="left" valign="top" colspan="1">Predisposing</td><td align="left" valign="top" rowspan="1" colspan="1">Age<xref rid="R35" ref-type="bibr"><sup>35 65</sup></xref></td><td align="left" valign="top" rowspan="1" colspan="1">Older age increases intervals by 1.7&#8201;x</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education<xref rid="R35" ref-type="bibr"><sup>35 65</sup></xref></td><td align="left" valign="top" rowspan="1" colspan="1">Low education=up&#8201;to 13.5&#8201;x longer</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Marital status<xref rid="R35" ref-type="bibr"><sup>35 38</sup></xref></td><td align="left" valign="top" rowspan="1" colspan="1">Being married=1.66&#8201;x higher risk of delay</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">Enabling</td><td align="left" valign="top" rowspan="1" colspan="1">Visited&#8805;4 health care facility</td><td align="left" valign="top" rowspan="1" colspan="1">1.24&#8211;2.6&#8201;x longer<xref rid="R36" ref-type="bibr"><sup>36 42</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Traditional healers visit</td><td align="left" valign="top" rowspan="1" colspan="1">1.68&#8201;x longer<xref rid="R44" ref-type="bibr"><sup>44</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No insurance</td><td align="left" valign="top" rowspan="1" colspan="1">Tripled risk of delay<xref rid="R65" ref-type="bibr"><sup>65</sup></xref></td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">Need</td><td align="left" valign="top" rowspan="1" colspan="1">No lump</td><td align="left" valign="top" rowspan="1" colspan="1">OR=3.87<xref rid="R44" ref-type="bibr"><sup>44</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fear of diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">AOR=1.29<xref rid="R65" ref-type="bibr"><sup>65</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No breast self-exam</td><td align="left" valign="top" rowspan="1" colspan="1">1.7&#8211;17&#8201;x longer<xref rid="R44" ref-type="bibr"><sup>44 65</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Contextual</td><td align="left" valign="top" rowspan="1" colspan="1">First contact at health centre</td><td align="left" valign="top" rowspan="1" colspan="1">1.19&#8201;x longer<xref rid="R42" ref-type="bibr"><sup>42</sup></xref></td></tr><tr><td rowspan="9" align="left" valign="top" colspan="1">Symptom recognition to diagnosis</td><td rowspan="4" align="left" valign="top" colspan="1">Predisposing</td><td align="left" valign="top" rowspan="1" colspan="1">Old age</td><td align="left" valign="top" rowspan="1" colspan="1">Older age linked to longer intervals</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Illiteracy</td><td align="left" valign="top" rowspan="1" colspan="1">Low literacy significantly increased intervals</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Menopausal status</td><td align="left" valign="top" rowspan="1" colspan="1">Menopausal women had longer intervals</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Long-term use of oral contraceptives</td><td align="left" valign="top" rowspan="1" colspan="1">Associated with longer intervals</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">Need</td><td align="left" valign="top" rowspan="1" colspan="1">Fibrocystic disease</td><td align="left" valign="top" rowspan="1" colspan="1">Fibrocystic disease history linked to longer intervals<xref rid="R29" ref-type="bibr"><sup>29 48</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No lump</td><td align="left" valign="top" rowspan="1" colspan="1">Absence of lump=prolonged interval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No family history</td><td align="left" valign="top" rowspan="1" colspan="1">Longer intervals in those without family history</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Contextual</td><td align="left" valign="top" rowspan="1" colspan="1">Rural residence</td><td align="left" valign="top" rowspan="1" colspan="1">Greater delays among rural patients</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#8805;100&#8201;km distance</td><td align="left" valign="top" rowspan="1" colspan="1">Long distance from care increased delays</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">Diagnosis to treatment initiation</td><td align="left" valign="top" rowspan="1" colspan="1">Predisposing</td><td align="left" valign="top" rowspan="1" colspan="1">Age &gt;45</td><td align="left" valign="top" rowspan="1" colspan="1">Older patients had 3.18&#8201;x higher odds of timely treatment<xref rid="R53" ref-type="bibr"><sup>53</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Enabling</td><td align="left" valign="top" rowspan="1" colspan="1">Financial constraint</td><td align="left" valign="top" rowspan="1" colspan="1">Linked to treatment delays<xref rid="R49" ref-type="bibr"><sup>49</sup></xref></td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Need</td><td align="left" valign="top" rowspan="1" colspan="1">Cancer stage</td><td align="left" valign="top" rowspan="1" colspan="1">Advanced stage=higher odds of timely care but also 1.78&#8201;x risk of delay<xref rid="R41" ref-type="bibr"><sup>41 43 51</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nodal status</td><td align="left" valign="top" rowspan="1" colspan="1">Nodal involvement associated with treatment delays<xref rid="R31" ref-type="bibr"><sup>31</sup></xref></td></tr></tbody></table><table-wrap-foot><fn fn-type="abbr"><p>HCP, healthcare providers.</p></fn></table-wrap-foot></table-wrap></sec></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>To our knowledge, this is the first scoping review to report on the metrics and definitions of various time intervals used to measure the breast cancer patient journey and related factors studied in African countries. The review identified seven key time points commonly studied, including symptom onset, recognising the need for help, engaging with informal care providers, presenting at a health facility, receiving a diagnosis, consulting a specialist,and starting treatment. Overall, breast cancer patients in Africa experienced a long care journey despite variations in median time intervals both between and within individual countries.</p><p>The time intervals from symptom recognition to first HCP contact, from first HCP contact to diagnosis and from diagnosis to treatment were generally longer than those reported in most studies from non-African countries.<xref rid="R68" ref-type="bibr">68</xref><xref rid="R70" ref-type="bibr">70</xref> Most studies included in this scoping review, with few exceptions, reported a median interval of 1&#8211;52 weeks between symptom recognition and first HCP contact, 1&#8211;20 weeks from HCP contact to diagnosis, 30&#8211;60 weeks between symptom detection and diagnosis and 5&#8211;12 weeks between diagnosis and initiation of treatment. They are significantly longer than those found in some developed countries such as the United Kingdom,<xref rid="R71" ref-type="bibr"><sup>71</sup></xref> the United States,<xref rid="R70" ref-type="bibr"><sup>70</sup></xref> France<xref rid="R69" ref-type="bibr"><sup>69</sup></xref> and Germany.<xref rid="R72" ref-type="bibr"><sup>72</sup></xref> However, they are comparable to estimates observed in some other LMICs, including Brazil,<xref rid="R73" ref-type="bibr"><sup>73</sup></xref> Colombia,<xref rid="R74" ref-type="bibr"><sup>74</sup></xref> Mexico and Malaysia.<xref rid="R75" ref-type="bibr"><sup>75 76</sup></xref></p><p>The time interval from symptom recognition to contact with a first HCP was studied more frequently, and this interval, along with the time from symptom detection to diagnosis, was longer compared with other time intervals. This finding is consistent with the two reviews on breast cancer diagnosis in LMICs.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> Previous reviews also identified the long time interval between symptom recognition and the first presentation to a HCP as a major cause for longer time intervals in breast cancer care.<xref rid="R15" ref-type="bibr"><sup>15 77</sup></xref> It suggests that delays often occur in the early stages of recognising and addressing breast cancer symptoms, which might reflect challenges like symptom awareness, healthcare access or cultural factors influencing health-seeking behaviour.</p><p>A significant methodological issue highlighted by this scoping review is the considerable variability in how the time from symptom recognition to initiation of treatment and its corresponding intervals were conceptualised and operationalised. This variability creates confusion, as identical terms are often used to refer to different intervals, leading to a lack of comparability. Despite the existence of validated tools and methods for assessing the timeliness of cancer care such as the Andersen model,<xref rid="R78" ref-type="bibr"><sup>78</sup></xref> the Model of Pathways to Treatment<xref rid="R23" ref-type="bibr"><sup>23</sup></xref> and the Aarhus Statement,<xref rid="R79" ref-type="bibr"><sup>79</sup></xref> only a small number of studies used these tools. The lack of standardised terms and metrics adds unnecessary complexity, jeopardising the potential value of the findings considering the diversity of social, economic and healthcare conditions across African countries. The WHO GBCI recommends clear time-bound benchmarks, achieving a diagnosis within 60 days of first presentation and initiating treatment within 30 days of diagnosis, to support timely and effective care. However, the limited uptake of standardised tools and metrics in African breast cancer research may hinder alignment with such global targets and impede efforts to improve outcomes.</p><p>Patients with breast cancer in many African countries often seek different initial points of contact on noticing their first symptoms. In several African countries, patients with breast cancer visit traditional healers or spiritual sites first after noticing early symptoms. These behaviours are likely to be influenced by cultural beliefs and misconceptions, including the perception that breast cancer is caused by supernatural forces, curses or ancestral punishment.<xref rid="R51" ref-type="bibr"><sup>51 80</sup></xref> Additionally, there is a widespread belief that cancer is fatal and incurable through conventional medical treatment, along with distrust in government healthcare systems and the social stigma associated with the disease.<xref rid="R81" ref-type="bibr"><sup>81</sup></xref> These cultural and traditional practices can result in many women presenting at health facilities with advanced stages of breast cancer, negatively affecting diagnosis and treatment outcomes.<xref rid="R82" ref-type="bibr"><sup>82</sup></xref> Indeed, three studies included in this current review identified visiting a traditional healer or spiritual places before contacting HCP as a significant predictor of longer time intervals in breast cancer journey. This is consistent with the findings of previous studies, where strong beliefs in traditional medicine and perhaps strong religious beliefs are deemed the main reasons for delays in presentation to HCP by patients with breast cancer in LMICs.<xref rid="R76" ref-type="bibr"><sup>76 80 83</sup></xref></p><p>There exist significant inequalities in breast cancer care in African countries. For example, older age,<xref rid="R22" ref-type="bibr"><sup>22 35 38 41 53 65</sup></xref> lower levels of education<xref rid="R22" ref-type="bibr"><sup>22 33 35</sup></xref> and rural residency<xref rid="R22" ref-type="bibr"><sup>22 36 52</sup></xref> are associated with longer time intervals. Additionally, the absence of a family history of breast cancer<xref rid="R40" ref-type="bibr"><sup>40 52</sup></xref> and not performing breast self-examination<xref rid="R34" ref-type="bibr"><sup>34 44 45 64</sup></xref> are also significant predictors of longer time intervals from symptom detection to initial healthcare contact and diagnosis.</p><p>The health system shortfalls and a lack of universal health coverage in African countries have contributed to the longer time intervals in breast cancer care. The lack of health insurance coverage,<xref rid="R65" ref-type="bibr"><sup>65</sup></xref> financial constraints<xref rid="R39" ref-type="bibr"><sup>39</sup></xref> and the need to travel long distances (over 100&#8201;km)<xref rid="R29" ref-type="bibr"><sup>29</sup></xref> present significant barriers for accessing breast cancer care. Poor infrastructure, workforce shortage and the absence of referral arrangements result in multiple paths for breast cancer care. Those who initially seek traditional therapy or visit multiple healthcare facilities are likely to experience additional longer time intervals in breast cancer diagnosis.<xref rid="R36" ref-type="bibr"><sup>36 42</sup></xref></p><p>This scoping review has revealed the importance of health literacy and patient empowerment for breast cancer care. In African countries, clinical characteristics like the absence of prior breast health issues, painless symptoms and no lump in the armpit are often linked to longer time intervals to HCP contact.<xref rid="R22" ref-type="bibr"><sup>22 52</sup></xref> Similarly, the absence of a palpable lump, fear of diagnosis,<xref rid="R65" ref-type="bibr"><sup>65</sup></xref> a history of fibrocystic disease,<xref rid="R29" ref-type="bibr"><sup>29 48</sup></xref> being married and long-term use of oral contraceptives<xref rid="R35" ref-type="bibr"><sup>35 38</sup></xref> were also identified as predictors of longer time intervals to diagnosis. Additionally, those diagnosed with late-stage cancer also experienced prolonged time intervals from diagnosis to treatment.<xref rid="R41" ref-type="bibr"><sup>41</sup></xref></p><p>This scoping review highlights several research gaps in breast cancer care in Africa. First, there is a scarcity of published data on treatment completion and follow-up due to most study designs ending with initiation of breast cancer treatment. This limits our understanding of loss to follow-up, which is a critical issue in resource-limited settings. This is a significant limitation, as loss to follow-up at any point in the care continuum may confound assessments of timeliness. Second, the existing studies primarily rely on hospital-based samples, which may not capture the full scope of the cancer burden in resource-limited settings where universal health coverage is lacking. A notable absence of community-based sampling limits the generalisability of findings as many patients may have never been diagnosed and treated in cancer care facilities. Moreover, patients who fail to complete the breast cancer care pathway, due to geographic, financial, sociocultural or health system barriers, are often excluded from analyses, which may limit the generalisability of findings to the broader population. Third, there is a paucity of qualitative studies exploring patients' experiences and barriers across the care pathway. Very few studies provide comprehensive insights into the entire journey, from initial symptom detection through to treatment initiation, encompassing all critical subintervals. Finally, there is a lack of locally developed, system-based criteria for assessing and defining the timeliness of breast cancer care.</p><sec id="s4-1"><title>Limitations</title><p>This scoping review has several limitations. First, many studies in the review were cross-sectional and retrospective, relying on patient recall to estimate key events, such as the time symptoms were first noticed, which introduces the risk of recall bias. There is also the potential for social desirability bias, which may result in underestimating patient, diagnostic and treatment time intervals. Another limitation is that, as in most scoping reviews, no formal quality appraisal of the included studies was conducted, leaving the strength of the evidence uncertain. Despite a comprehensive literature search, some relevant studies may have been missed due to accessibility issues, and only English-language publications were included, potentially excluding literature in other languages. This scoping review also excluded those studies focused primarily on screening asymptomatic individuals. Finally, while the review covers the care pathway up to treatment initiation, it does not examine treatment completion.</p></sec></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>The available evidence reveals significant variations both between and within African countries in how the timeliness of breast cancer care and time intervals are conceptualised and measured. These differences highlight the need for a greater use of validated, standardised tools to assess timeliness in a more consistent and comparable manner, which would better inform interventions aimed at reducing delays in breast cancer care. Further research, using common and standardise metrics, is needed to evaluate and improve timeliness of breast cancer care.</p><p>Breast cancer care in African countries is a long and complex journey, involving multiple care providers and paths, including decisions made by patients, their family members, traditional healers and religious providers, in addition to those of formal HCP.</p><p>This review also underscores the dual challenges relating to patient-mediated and health system-mediated factors for improving the breast cancer care journey in Africa. On the patient side, awareness campaigns tailored to cultural contexts and targeting older women and rural populations are crucial. On the system side, strengthening diagnostic infrastructure, improving referral pathways and addressing financial and geographic barriers are essential to ensure timely care. Addressing these interconnected challenges requires a multifaceted approach that integrates community education with systemic healthcare improvements to improve breast cancer outcomes and reduce related mortality across Africa. Engaging traditional and religious leaders in education and referrals to formal care should also be explored.</p><p>Future research should prioritise community-based sampling and qualitative studies to gain a more comprehensive understanding of breast cancer patterns and challenges. Additionally, studies focusing on treatment completion rates, follow-up care for breast cancer patients and the impact of failure to complete treatment are essential to address gaps in the care continuum and improve patient outcomes.</p></sec><sec sec-type="supplementary-material" id="s6"><title>Supplementary material</title><supplementary-material id="ST1" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2024-098087</object-id><label>online supplemental table 1</label><media xlink:href="bmjopen-15-8-s001.docx" id="d67e2713" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="ST2" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2024-098087</object-id><label>online supplemental table 2</label><media xlink:href="bmjopen-15-8-s002.docx" id="d67e2718" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><ack><title>Acknowledgements</title><p>We are grateful to the La Trobe University Research Graduate Scholarship (LTURGS) for making available the necessary resources for completion of this study protocol.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> This review is funded by La Trobe University Research Graduate Scholarship (LTURGS). The funder didn&#8217;t influence the results/outcomes of the study despite author affiliations with the funder.</p></fn><fn fn-type="other"><p>Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (<ext-link xlink:href="https://doi.org/10.1136/bmjopen-2024-098087" ext-link-type="uri">https://doi.org/10.1136/bmjopen-2024-098087</ext-link>).</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Patient consent for publication:</bold> Not applicable.</p></fn><fn fn-type="other"><p><bold>Ethics approval:</bold> Not applicable.</p></fn><fn fn-type="other"><p><bold>Patient and public involvement:</bold> Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Miller</surname><given-names>KD</given-names></name><name name-style="western"><surname>Wagle</surname><given-names>NS</given-names></name><etal>et al</etal></person-group><article-title>Cancer statistics, 2023</article-title><source><italic toggle="yes">CA Cancer J Clin</italic></source><year>2023</year><volume>73</volume><fpage>17</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.3322/caac.21763</pub-id><pub-id pub-id-type="pmid">36633525</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Cancer, W.B</collab></person-group><year>2024</year><comment>Available</comment><ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/breast-cancer" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/breast-cancer</ext-link></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bray</surname><given-names>F</given-names></name><name name-style="western"><surname>Laversanne</surname><given-names>M</given-names></name><name name-style="western"><surname>Sung</surname><given-names>H</given-names></name><etal>et al</etal></person-group><article-title>Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source><italic toggle="yes">CA Cancer J Clin</italic></source><year>2024</year><volume>74</volume><fpage>229</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.3322/caac.21834</pub-id><pub-id pub-id-type="pmid">38572751</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joko-Fru</surname><given-names>WY</given-names></name><name name-style="western"><surname>Jedy-Agba</surname><given-names>E</given-names></name><name name-style="western"><surname>Korir</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>The evolving epidemic of breast cancer in sub-Saharan Africa: Results from the African Cancer Registry Network</article-title><source>Int J Cancer</source><year>2020</year><volume>147</volume><fpage>2131</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1002/ijc.33014</pub-id><pub-id pub-id-type="pmid">32306390</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>R</given-names></name></person-group><article-title>Breast cancer burden in Africa: evidence from GLOBOCAN 2018</article-title><source>J Public Health (Bangkok)</source><year>2021</year><volume>43</volume><fpage>763</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1093/pubmed/fdaa099</pub-id><pub-id pub-id-type="pmid">32657321</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mwamba</surname><given-names>M</given-names></name><name name-style="western"><surname>Lombe</surname><given-names>DC</given-names></name><name name-style="western"><surname>Msadabwe</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>A Narrative Synthesis of Literature on the Barriers to Timely Diagnosis and Treatment of Cancer in Sub-Saharan Africa</article-title><source>Clin Oncol</source><year>2023</year><volume>35</volume><fpage>e537</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.clon.2023.05.011</pub-id><pub-id pub-id-type="pmid">37302880</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duggan</surname><given-names>C</given-names></name><name name-style="western"><surname>Trapani</surname><given-names>D</given-names></name><name name-style="western"><surname>Ilbawi</surname><given-names>AM</given-names></name><etal>et al</etal></person-group><article-title>National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis</article-title><source>Lancet Oncol</source><year>2021</year><volume>22</volume><fpage>1632</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(21)00462-9</pub-id><pub-id pub-id-type="pmid">34653370</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brinton</surname><given-names>LA</given-names></name><name name-style="western"><surname>Figueroa</surname><given-names>JD</given-names></name><name name-style="western"><surname>Awuah</surname><given-names>B</given-names></name><etal>et al</etal></person-group><article-title>Breast cancer in Sub-Saharan Africa: opportunities for prevention</article-title><source>Breast Cancer Res Treat</source><year>2014</year><volume>144</volume><fpage>467</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1007/s10549-014-2868-z</pub-id><pub-id pub-id-type="pmid">24604092</pub-id><pub-id pub-id-type="pmcid">PMC4023680</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agodirin</surname><given-names>OS</given-names></name><name name-style="western"><surname>Aremu</surname><given-names>I</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>GA</given-names></name><etal>et al</etal></person-group><article-title>Prevalence of Themes Linked to Delayed Presentation of Breast Cancer in Africa: A Meta-Analysis of Patient-Reported Studies</article-title><source>JCO Glob Oncol</source><year>2020</year><volume>6</volume><fpage>731</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1200/JGO.19.00402</pub-id><pub-id pub-id-type="pmid">32437263</pub-id><pub-id pub-id-type="pmcid">PMC7268898</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrios</surname><given-names>CH</given-names></name></person-group><article-title>Global challenges in breast cancer detection and treatment</article-title><source>Breast</source><year>2022</year><volume>62 Suppl 1</volume><fpage>S3</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.breast.2022.02.003</pub-id><pub-id pub-id-type="pmid">35219542</pub-id><pub-id pub-id-type="pmcid">PMC9097801</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Omotoso</surname><given-names>O</given-names></name><name name-style="western"><surname>Teibo</surname><given-names>JO</given-names></name><name name-style="western"><surname>Atiba</surname><given-names>FA</given-names></name><etal>et al</etal></person-group><article-title>Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions</article-title><source>Int J Equity Health</source><year>2023</year><volume>22</volume><elocation-id>189</elocation-id><pub-id pub-id-type="doi">10.1186/s12939-023-01962-y</pub-id><pub-id pub-id-type="pmid">37697315</pub-id><pub-id pub-id-type="pmcid">PMC10496173</pub-id><related-article related-article-type="expression-of-concern" ext-link-type="pmc" xlink:href="PMC11721553"/></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elliss-Brookes</surname><given-names>L</given-names></name><name name-style="western"><surname>McPhail</surname><given-names>S</given-names></name><name name-style="western"><surname>Ives</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets</article-title><source>Br J Cancer</source><year>2012</year><volume>107</volume><fpage>1220</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/bjc.2012.408</pub-id><pub-id pub-id-type="pmid">22996611</pub-id><pub-id pub-id-type="pmcid">PMC3494426</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>BO</given-names></name><name name-style="western"><surname>Ilbawi</surname><given-names>AM</given-names></name><name name-style="western"><surname>El Saghir</surname><given-names>NS</given-names></name></person-group><article-title>Breast cancer in low and middle income countries (LMICs): a shifting tide in global health</article-title><source>Breast J</source><year>2015</year><volume>21</volume><fpage>111</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/tbj.12357</pub-id><pub-id pub-id-type="pmid">25444441</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>WHO, T.W.H.O</collab></person-group><article-title>The global breast cancer initiative</article-title><year>2021</year><comment>Available</comment><ext-link xlink:href="https://www.who.int/initiatives/global-breast-cancer-initiative" ext-link-type="uri">https://www.who.int/initiatives/global-breast-cancer-initiative</ext-link></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nnaji</surname><given-names>CA</given-names></name><name name-style="western"><surname>Ezenwankwo</surname><given-names>EF</given-names></name><name name-style="western"><surname>Kuodi</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Timeliness of diagnosis of breast and cervical cancers and associated factors in low-income and middle-income countries: a scoping review</article-title><source>BMJ Open</source><year>2022</year><volume>12</volume><elocation-id>e057685</elocation-id><pub-id pub-id-type="doi">10.1136/bmjopen-2021-057685</pub-id><pub-id pub-id-type="pmcid">PMC8819798</pub-id><pub-id pub-id-type="pmid">35121607</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>M</given-names></name><name name-style="western"><surname>Westcombe</surname><given-names>A</given-names></name><name name-style="western"><surname>Love</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Influence of delay on survival in patients with breast cancer: a systematic review</article-title><source>The Lancet</source><year>1999</year><volume>353</volume><fpage>1119</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(99)02143-1</pub-id><pub-id pub-id-type="pmid">10209974</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanna</surname><given-names>TP</given-names></name><name name-style="western"><surname>King</surname><given-names>WD</given-names></name><name name-style="western"><surname>Thibodeau</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Mortality due to cancer treatment delay: systematic review and meta-analysis</article-title><source>BMJ</source><year>2020</year><volume>371</volume><elocation-id>m4087</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.m4087</pub-id><pub-id pub-id-type="pmid">33148535</pub-id><pub-id pub-id-type="pmcid">PMC7610021</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katoue</surname><given-names>MG</given-names></name><name name-style="western"><surname>Cerda</surname><given-names>AA</given-names></name><name name-style="western"><surname>Garc&#237;a</surname><given-names>LY</given-names></name><etal>et al</etal></person-group><article-title>Healthcare system development in the Middle East and North Africa region: Challenges, endeavors and prospective opportunities</article-title><source>Front Public Health</source><year>2022</year><volume>10</volume><elocation-id>1045739</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2022.1045739</pub-id><pub-id pub-id-type="pmid">36620278</pub-id><pub-id pub-id-type="pmcid">PMC9815436</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salisu</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Mirlashari</surname><given-names>J</given-names></name><name name-style="western"><surname>Varaei</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Limited access to care for persons with breast cancer in Africa: A systematic review</article-title><source>Eur J Oncol Nurs</source><year>2021</year><volume>50</volume><fpage>101867</fpage><pub-id pub-id-type="doi">10.1016/j.ejon.2020.101867</pub-id><pub-id pub-id-type="pmid">33276292</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asuzu</surname><given-names>CC</given-names></name><name name-style="western"><surname>Akin-Odanye</surname><given-names>EO</given-names></name><name name-style="western"><surname>Asuzu</surname><given-names>MC</given-names></name><etal>et al</etal></person-group><article-title>A socio-cultural study of traditional healers role in African health care</article-title><source>Infect Agents Cancer</source><year>2019</year><volume>14</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.1186/s13027-019-0232-y</pub-id><pub-id pub-id-type="pmcid">PMC6585125</pub-id><pub-id pub-id-type="pmid">31249608</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brand</surname><given-names>NR</given-names></name><name name-style="western"><surname>Qu</surname><given-names>LG</given-names></name><name name-style="western"><surname>Chao</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Delays and Barriers to Cancer Care in Low- and Middle-Income Countries: A Systematic Review</article-title><source>Oncologist</source><year>2019</year><volume>24</volume><fpage>e1371</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.2019-0057</pub-id><pub-id pub-id-type="pmid">31387949</pub-id><pub-id pub-id-type="pmcid">PMC6975966</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hassen</surname><given-names>AM</given-names></name><name name-style="western"><surname>Hussien</surname><given-names>FM</given-names></name><name name-style="western"><surname>Asfaw</surname><given-names>ZA</given-names></name><etal>et al</etal></person-group><article-title>Factors Associated with Delay in Breast Cancer Presentation at the Only Oncology Center in North East Ethiopia: A Cross-Sectional Study</article-title><source>J Multidiscip Healthc</source><year>2021</year><volume>14</volume><fpage>681</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.2147/JMDH.S301337</pub-id><pub-id pub-id-type="pmid">33776446</pub-id><pub-id pub-id-type="pmcid">PMC7989045</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>SE</given-names></name><name name-style="western"><surname>Walter</surname><given-names>FM</given-names></name><name name-style="western"><surname>Webster</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>The model of pathways to treatment: conceptualization and integration with existing theory</article-title><source>Br J Health Psychol</source><year>2013</year><volume>18</volume><fpage>45</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1111/j.2044-8287.2012.02077.x</pub-id><pub-id pub-id-type="pmid">22536840</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alkhawaldeh</surname><given-names>A</given-names></name><name name-style="western"><surname>ALBashtawy</surname><given-names>M</given-names></name><name name-style="western"><surname>Rayan</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Application and Use of Andersen&#8217;s Behavioral Model as Theoretical Framework: A Systematic Literature Review from 2012-2021</article-title><source>Iran J Public Health</source><year>2023</year><volume>52</volume><fpage>1346</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.18502/ijph.v52i7.13236</pub-id><pub-id pub-id-type="pmid">37593505</pub-id><pub-id pub-id-type="pmcid">PMC10430393</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arksey</surname><given-names>H</given-names></name><name name-style="western"><surname>O&#8217;Malley</surname><given-names>L</given-names></name></person-group><article-title>Scoping studies: towards a methodological framework</article-title><source>Int J Soc Res Methodol</source><year>2005</year><volume>8</volume><fpage>19</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1080/1364557032000119616</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levac</surname><given-names>D</given-names></name><name name-style="western"><surname>Colquhoun</surname><given-names>H</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>KK</given-names></name></person-group><article-title>Scoping studies: advancing the methodology</article-title><source>Implement Sci</source><year>2010</year><volume>5</volume><fpage>69</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-5-69</pub-id><pub-id pub-id-type="pmid">20854677</pub-id><pub-id pub-id-type="pmcid">PMC2954944</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>MD</given-names></name></person-group><source>The joanna briggs institute reviewers&#8217; manual 2015: methodology for JBI scoping reviews</source><year>2015</year></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kibret</surname><given-names>AA</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><etal>et al</etal></person-group><article-title>Patient journey and timeliness of care for patients with breast cancer in Africa: a scoping review protocol</article-title><source>BMJ Open</source><year>2024</year><volume>14</volume><elocation-id>e081256</elocation-id><pub-id pub-id-type="doi">10.1136/bmjopen-2023-081256</pub-id><pub-id pub-id-type="pmcid">PMC11381707</pub-id><pub-id pub-id-type="pmid">39242165</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maghous</surname><given-names>A</given-names></name><name name-style="western"><surname>Rais</surname><given-names>F</given-names></name><name name-style="western"><surname>Ahid</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Factors influencing diagnosis delay of advanced breast cancer in Moroccan women</article-title><source>BMC Cancer</source><year>2016</year><volume>16</volume><elocation-id>356</elocation-id><pub-id pub-id-type="doi">10.1186/s12885-016-2394-y</pub-id><pub-id pub-id-type="pmid">27268201</pub-id><pub-id pub-id-type="pmcid">PMC4897875</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galukande</surname><given-names>M</given-names></name><name name-style="western"><surname>Mirembe</surname><given-names>F</given-names></name><name name-style="western"><surname>Wabinga</surname><given-names>H</given-names></name></person-group><article-title>Patient Delay in Accessing Breast Cancer Care in a Sub Saharan African Country: Uganda</article-title><source>Br J Med Med Res</source><year>2014</year><volume>4</volume><fpage>2599</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.9734/BJMMR/2014/7293#sthash.PglzE4b6.dpuf</pub-id><pub-id pub-id-type="pmid">25984460</pub-id><pub-id pub-id-type="pmcid">PMC4430806</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mimouni</surname><given-names>H</given-names></name><name name-style="western"><surname>Hassouni</surname><given-names>K</given-names></name><name name-style="western"><surname>El marnissi</surname><given-names>B</given-names></name><etal>et al</etal></person-group><article-title>The patient, diagnosis and treatment delay of the care pathway of patients with breast Cancer in Morocco</article-title><source>Ann Cancer Res Therap</source><year>2022</year><volume>30</volume><fpage>11</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.4993/acrt.30.11</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moodley</surname><given-names>J</given-names></name><name name-style="western"><surname>Cairncross</surname><given-names>L</given-names></name><name name-style="western"><surname>Naiker</surname><given-names>T</given-names></name><etal>et al</etal></person-group><article-title>Understanding pathways to breast cancer diagnosis among women in the Western Cape Province, South Africa: a qualitative study</article-title><source>BMJ Open</source><year>2016</year><volume>6</volume><elocation-id>e009905</elocation-id><pub-id pub-id-type="doi">10.1136/bmjopen-2015-009905</pub-id><pub-id pub-id-type="pmcid">PMC4716174</pub-id><pub-id pub-id-type="pmid">26729392</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agodirin</surname><given-names>O</given-names></name><name name-style="western"><surname>Olatoke</surname><given-names>S</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>G</given-names></name><etal>et al</etal></person-group><article-title>Presentation intervals and the impact of delay on breast cancer progression in a black African population</article-title><source>BMC Public Health</source><year>2020</year><volume>20</volume><elocation-id>962</elocation-id><pub-id pub-id-type="doi">10.1186/s12889-020-09074-w</pub-id><pub-id pub-id-type="pmid">32560711</pub-id><pub-id pub-id-type="pmcid">PMC7304119</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balhi</surname><given-names>S</given-names></name><name name-style="western"><surname>Khiari</surname><given-names>H</given-names></name><name name-style="western"><surname>Hsairi</surname><given-names>M</given-names></name></person-group><article-title>Factors Associated with Diagnostic Delays among Tunisian Breast Cancer Patients</article-title><source>Asian Pac J Cancer Prev</source><year>2023</year><volume>24</volume><fpage>471</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.31557/APJCP.2023.24.2.471</pub-id><pub-id pub-id-type="pmid">36853295</pub-id><pub-id pub-id-type="pmcid">PMC10162604</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zahfir</surname><given-names>H</given-names></name><name name-style="western"><surname>Zoukal</surname><given-names>S</given-names></name><name name-style="western"><surname>Hassoune</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Factors Related to Delayed Diagnosis and Treatment of Breast Cancer Among Moroccan Women in Casablanca</article-title><source><italic toggle="yes">Indian J Gynecol Oncolog</italic></source><year>2022</year><volume>20</volume><fpage>68</fpage><pub-id pub-id-type="doi">10.1007/s40944-022-00668-3</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pace</surname><given-names>LE</given-names></name><name name-style="western"><surname>Mpunga</surname><given-names>T</given-names></name><name name-style="western"><surname>Hategekimana</surname><given-names>V</given-names></name><etal>et al</etal></person-group><article-title>Delays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in Rwanda</article-title><source>Oncologist</source><year>2015</year><volume>20</volume><fpage>780</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.2014-0493</pub-id><pub-id pub-id-type="pmid">26032138</pub-id><pub-id pub-id-type="pmcid">PMC4492236</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Odongo</surname><given-names>J</given-names></name><name name-style="western"><surname>Makumbi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kalungi</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Patient delay factors in women presenting with breast cancer in a low income country</article-title><source>BMC Res Notes</source><year>2015</year><volume>8</volume><elocation-id>467</elocation-id><pub-id pub-id-type="doi">10.1186/s13104-015-1438-8</pub-id><pub-id pub-id-type="pmid">26395344</pub-id><pub-id pub-id-type="pmcid">PMC4580128</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olarewaju</surname><given-names>SO</given-names></name><name name-style="western"><surname>Oyekunle</surname><given-names>EO</given-names></name><name name-style="western"><surname>Bamiro</surname><given-names>AO</given-names></name></person-group><article-title>Effect of Sociodemographic Variables on Patient and Diagnostic Delay of Breast Cancer at the Foremost Health Care Institution in Nigeria</article-title><source>J Glob Oncol</source><year>2019</year><volume>5</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1200/JGO.19.00108</pub-id><pub-id pub-id-type="pmcid">PMC6690652</pub-id><pub-id pub-id-type="pmid">31348736</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salih</surname><given-names>AM</given-names></name><name name-style="western"><surname>Alfaki</surname><given-names>MM</given-names></name><name name-style="western"><surname>Alam-Elhuda</surname><given-names>DM</given-names></name><etal>et al</etal></person-group><article-title>Factors Delaying Presentation of Sudanese Breast Cancer Patients: an Analysis Using Andersen&#8217;s Model</article-title><source>Asian Pac J Cancer Prev</source><year>2016</year><volume>17</volume><fpage>2105</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.7314/apjcp.2016.17.4.2105</pub-id><pub-id pub-id-type="pmid">27221903</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="preprint"><person-group person-group-type="author"><name name-style="western"><surname>Muhammed</surname><given-names>JA</given-names></name><name name-style="western"><surname>Kroeber</surname><given-names>ES</given-names></name><name name-style="western"><surname>Deribe</surname><given-names>B</given-names></name><etal>et al</etal></person-group><article-title>Prevalence and factors associated with delay in presentation of breast cancer patients in ethiopia: a cross-sectional institution-based study</article-title><source><italic toggle="yes">medRxiv</italic></source><comment>Preprint</comment><year>2022</year><pub-id pub-id-type="doi">10.1101/2022.11.01.22281792</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moodley</surname><given-names>J</given-names></name><name name-style="western"><surname>Cairncross</surname><given-names>L</given-names></name><name name-style="western"><surname>Naiker</surname><given-names>T</given-names></name><etal>et al</etal></person-group><article-title>From symptom discovery to treatment - women&#8217;s pathways to breast cancer care: a cross-sectional study</article-title><source>BMC Cancer</source><year>2018</year><volume>18</volume><elocation-id>312</elocation-id><pub-id pub-id-type="doi">10.1186/s12885-018-4219-7</pub-id><pub-id pub-id-type="pmid">29562894</pub-id><pub-id pub-id-type="pmcid">PMC5863383</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gebremariam</surname><given-names>A</given-names></name><name name-style="western"><surname>Addissie</surname><given-names>A</given-names></name><name name-style="western"><surname>Worku</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Time intervals experienced between first symptom recognition and pathologic diagnosis of breast cancer in Addis Ababa, Ethiopia: a cross-sectional study</article-title><source>BMJ Open</source><year>2019</year><volume>9</volume><elocation-id>e032228</elocation-id><pub-id pub-id-type="doi">10.1136/bmjopen-2019-032228</pub-id><pub-id pub-id-type="pmcid">PMC6858206</pub-id><pub-id pub-id-type="pmid">31719089</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foerster</surname><given-names>M</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>F</given-names></name><name name-style="western"><surname>Zietsman</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Dissecting the journey to breast cancer diagnosis in sub-Saharan Africa: Findings from the multicountry ABC-DO cohort study</article-title><source>Int J Cancer</source><year>2021</year><volume>148</volume><fpage>340</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1002/ijc.33209</pub-id><pub-id pub-id-type="pmid">32663320</pub-id><pub-id pub-id-type="pmcid">PMC7754476</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Darr&#233;</surname><given-names>T</given-names></name><name name-style="western"><surname>Tchandikou</surname><given-names>L</given-names></name><name name-style="western"><surname>Simgban</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Factors associated with late diagnosis of breast cancer in women in Togo, Sub-Saharan Africa</article-title><source>BMC Womens Health</source><year>2023</year><volume>23</volume><elocation-id>106</elocation-id><pub-id pub-id-type="doi">10.1186/s12905-023-02257-8</pub-id><pub-id pub-id-type="pmid">36918873</pub-id><pub-id pub-id-type="pmcid">PMC10012487</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grosse Frie</surname><given-names>K</given-names></name><name name-style="western"><surname>Kamat&#233;</surname><given-names>B</given-names></name><name name-style="western"><surname>Traor&#233;</surname><given-names>CB</given-names></name><etal>et al</etal></person-group><article-title>Factors associated with time to first healthcare visit, diagnosis and treatment, and their impact on survival among breast cancer patients in Mali</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><elocation-id>e0207928</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0207928</pub-id><pub-id pub-id-type="pmid">30496219</pub-id><pub-id pub-id-type="pmcid">PMC6264812</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grosse Frie</surname><given-names>K</given-names></name><name name-style="western"><surname>Kamat&#233;</surname><given-names>B</given-names></name><name name-style="western"><surname>Traor&#233;</surname><given-names>CB</given-names></name><etal>et al</etal></person-group><article-title>Health system organisation and patient pathways: breast care patients&#8217; trajectories and medical doctors&#8217; practice in Mali</article-title><source>BMC Public Health</source><year>2019</year><volume>19</volume><elocation-id>204</elocation-id><pub-id pub-id-type="doi">10.1186/s12889-019-6532-8</pub-id><pub-id pub-id-type="pmid">30777038</pub-id><pub-id pub-id-type="pmcid">PMC6379964</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grosse Frie</surname><given-names>K</given-names></name><name name-style="western"><surname>Samoura</surname><given-names>H</given-names></name><name name-style="western"><surname>Diop</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Why Do Women with Breast Cancer Get Diagnosed and Treated Late in Sub-Saharan Africa? Perspectives from Women and Patients in Bamako, Mali</article-title><source><italic toggle="yes">Breast Care (Basel</italic>)</source><year>2018</year><volume>13</volume><fpage>39</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1159/000481087</pub-id><pub-id pub-id-type="pmid">29950966</pub-id><pub-id pub-id-type="pmcid">PMC6016059</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ermiah</surname><given-names>E</given-names></name><name name-style="western"><surname>Abdalla</surname><given-names>F</given-names></name><name name-style="western"><surname>Buhmeida</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Diagnosis delay in Libyan female breast cancer</article-title><source>BMC Res Notes</source><year>2012</year><volume>5</volume><elocation-id>452</elocation-id><pub-id pub-id-type="doi">10.1186/1756-0500-5-452</pub-id><pub-id pub-id-type="pmid">22909280</pub-id><pub-id pub-id-type="pmcid">PMC3542159</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daniel</surname><given-names>O</given-names></name><name name-style="western"><surname>Ashrafi</surname><given-names>A</given-names></name><name name-style="western"><surname>Muthoni</surname><given-names>MA</given-names></name><etal>et al</etal></person-group><article-title>Delayed breast cancer presentation, diagnosis, and treatment in Kenya</article-title><source>Breast Cancer Res Treat</source><year>2023</year><volume>202</volume><fpage>515</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1007/s10549-023-07067-y</pub-id><pub-id pub-id-type="pmid">37668821</pub-id><pub-id pub-id-type="pmcid">PMC11906215</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ukwenya</surname><given-names>AY</given-names></name><name name-style="western"><surname>Yusufu</surname><given-names>LMD</given-names></name><name name-style="western"><surname>Nmadu</surname><given-names>PT</given-names></name><etal>et al</etal></person-group><article-title>Delayed treatment of symptomatic breast cancer: the experience from Kaduna, Nigeria</article-title><source>S Afr J Surg</source><year>2008</year><volume>46</volume><fpage>106</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">19051953</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tesfaw</surname><given-names>A</given-names></name><name name-style="western"><surname>Alebachew</surname><given-names>W</given-names></name><name name-style="western"><surname>Tiruneh</surname><given-names>M</given-names></name></person-group><article-title>Why women with breast cancer presented late to health care facility in North-west Ethiopia? A qualitative study</article-title><source>PLoS One</source><year>2020</year><volume>15</volume><elocation-id>e0243551</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0243551</pub-id><pub-id pub-id-type="pmid">33275642</pub-id><pub-id pub-id-type="pmcid">PMC7717512</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tesfaw</surname><given-names>A</given-names></name><name name-style="western"><surname>Demis</surname><given-names>S</given-names></name><name name-style="western"><surname>Munye</surname><given-names>T</given-names></name><etal>et al</etal></person-group><article-title>Patient Delay and Contributing Factors Among Breast Cancer Patients at Two Cancer Referral Centres in Ethiopia: A Cross-Sectional Study</article-title><source>J Multidiscip Healthc</source><year>2020</year><volume>13</volume><fpage>1391</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.2147/JMDH.S275157</pub-id><pub-id pub-id-type="pmid">33173301</pub-id><pub-id pub-id-type="pmcid">PMC7646382</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teshome</surname><given-names>B</given-names></name><name name-style="western"><surname>Trabitzsch</surname><given-names>J</given-names></name><name name-style="western"><surname>Afework</surname><given-names>T</given-names></name><etal>et al</etal></person-group><article-title>Perceived barriers to timely treatment initiation and social support status among women with breast cancer in Ethiopia</article-title><source>PLoS One</source><year>2021</year><volume>16</volume><elocation-id>e0257163</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0257163</pub-id><pub-id pub-id-type="pmid">34516552</pub-id><pub-id pub-id-type="pmcid">PMC8437283</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Patient delay and associated factors among Chinese women with breast cancer</article-title><source>Medicine (Baltimore)</source><year>2019</year><volume>98</volume><elocation-id>e17454</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000017454</pub-id><pub-id pub-id-type="pmid">31577773</pub-id><pub-id pub-id-type="pmcid">PMC6783180</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unger-Salda&#241;a</surname><given-names>K</given-names></name></person-group><article-title>Challenges to the early diagnosis and treatment of breast cancer in developing countries</article-title><source>World J Clin Oncol</source><year>2014</year><volume>5</volume><fpage>465</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.5306/wjco.v5.i3.465</pub-id><pub-id pub-id-type="pmid">25114860</pub-id><pub-id pub-id-type="pmcid">PMC4127616</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unger-Salda&#241;a</surname><given-names>K</given-names></name><name name-style="western"><surname>Infante-Casta&#241;eda</surname><given-names>C</given-names></name></person-group><article-title>Delay of medical care for symptomatic breast cancer: a literature review</article-title><source>Salud Publica Mex</source><year>2009</year><volume>51 Suppl 2</volume><fpage>s270</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1590/s0036-36342009000800018</pub-id><pub-id pub-id-type="pmid">19967283</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramirez</surname><given-names>A</given-names></name><name name-style="western"><surname>Westcombe</surname><given-names>A</given-names></name><name name-style="western"><surname>Burgess</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Factors predicting delayed presentation of symptomatic breast cancer: a systematic review</article-title><source>The Lancet</source><year>1999</year><volume>353</volume><fpage>1127</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(99)02142-X</pub-id><pub-id pub-id-type="pmid">10209975</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hansen</surname><given-names>RP</given-names></name><name name-style="western"><surname>Olesen</surname><given-names>F</given-names></name><name name-style="western"><surname>S&#248;rensen</surname><given-names>HT</given-names></name><etal>et al</etal></person-group><article-title>Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study</article-title><source>BMC Health Serv Res</source><year>2008</year><volume>8</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/1472-6963-8-49</pub-id><pub-id pub-id-type="pmid">18307790</pub-id><pub-id pub-id-type="pmcid">PMC2311301</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gyenwali</surname><given-names>D</given-names></name><name name-style="western"><surname>Khanal</surname><given-names>G</given-names></name><name name-style="western"><surname>Paudel</surname><given-names>R</given-names></name><etal>et al</etal></person-group><article-title>Estimates of delays in diagnosis of cervical cancer in Nepal</article-title><source><italic toggle="yes">BMC Womens Health</italic></source><year>2014</year><volume>14</volume><fpage>29</fpage><pub-id pub-id-type="doi">10.1186/1472-6874-14-29</pub-id><pub-id pub-id-type="pmid">24533670</pub-id><pub-id pub-id-type="pmcid">PMC3932513</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olesen</surname><given-names>F</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>RP</given-names></name><name name-style="western"><surname>Vedsted</surname><given-names>P</given-names></name></person-group><article-title>Delay in diagnosis: the experience in Denmark</article-title><source>Br J Cancer</source><year>2009</year><volume>101 Suppl 2</volume><fpage>S5</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6605383</pub-id><pub-id pub-id-type="pmid">19956163</pub-id><pub-id pub-id-type="pmcid">PMC2790711</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tazi</surname><given-names>MA</given-names></name><name name-style="western"><surname>Er-Raki</surname><given-names>A</given-names></name><name name-style="western"><surname>Benjaafar</surname><given-names>N</given-names></name></person-group><article-title>Cancer incidence in Rabat, Morocco: 2006-2008</article-title><source>Ecancermedicalscience</source><year>2013</year><volume>7</volume><elocation-id>338</elocation-id><pub-id pub-id-type="doi">10.3332/ecancer.2013.338</pub-id><pub-id pub-id-type="pmid">23940493</pub-id><pub-id pub-id-type="pmcid">PMC3737118</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gebremariam</surname><given-names>A</given-names></name><name name-style="western"><surname>Assefa</surname><given-names>M</given-names></name><name name-style="western"><surname>Addissie</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Delayed initiation of adjuvant chemotherapy among women with breast cancer in Addis Ababa, Ethiopia</article-title><source>Breast Cancer Res Treat</source><year>2021</year><volume>187</volume><fpage>877</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1007/s10549-021-06131-9</pub-id><pub-id pub-id-type="pmid">33599864</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joko-Fru</surname><given-names>WY</given-names></name><name name-style="western"><surname>Miranda-Filho</surname><given-names>A</given-names></name><name name-style="western"><surname>Soerjomataram</surname><given-names>I</given-names></name><etal>et al</etal></person-group><article-title>Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: A population-based registry study</article-title><source>Int J Cancer</source><year>2020</year><volume>146</volume><fpage>1208</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1002/ijc.32406</pub-id><pub-id pub-id-type="pmid">31087650</pub-id><pub-id pub-id-type="pmcid">PMC7079125</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jemebere</surname><given-names>W</given-names></name></person-group><article-title>Barriers Associated with Presentation Delay among Breast Cancer Patients at Hawassa University Comprehensive and Specialized Hospital, Southern Ethiopia</article-title><source><italic toggle="yes">Int J Caring Sci</italic></source><year>2019</year><volume>12</volume><pub-id pub-id-type="doi">10.2139/ssrn.3486109</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdel-Fattah</surname><given-names>MM</given-names></name></person-group><article-title>Patient-and system-related diagnostic delay in breast cancer</article-title><source>Eur J Public Health</source><year>1999</year><volume>9</volume><fpage>15</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1093/eurpub/9.1.15</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrova</surname><given-names>D</given-names></name><name name-style="western"><surname>Garrido</surname><given-names>D</given-names></name><name name-style="western"><surname>&#352;pac&#237;rov&#225;</surname><given-names>Z</given-names></name><etal>et al</etal></person-group><article-title>Duration of the patient interval in breast cancer and factors associated with longer delays in low-and middle-income countries: A systematic review with meta-analysis</article-title><source>Psychooncology</source><year>2023</year><volume>32</volume><fpage>13</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1002/pon.6064</pub-id><pub-id pub-id-type="pmid">36345154</pub-id><pub-id pub-id-type="pmcid">PMC10100001</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martei</surname><given-names>YM</given-names></name><name name-style="western"><surname>Vanderpuye</surname><given-names>V</given-names></name><name name-style="western"><surname>Jones</surname><given-names>BA</given-names></name></person-group><article-title>Fear of Mastectomy Associated with Delayed Breast Cancer Presentation Among Ghanaian Women</article-title><source>Oncologist</source><year>2018</year><volume>23</volume><fpage>1446</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.2017-0409</pub-id><pub-id pub-id-type="pmid">29959283</pub-id><pub-id pub-id-type="pmcid">PMC6292549</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rivera-Franco</surname><given-names>MM</given-names></name><name name-style="western"><surname>Leon-Rodriguez</surname><given-names>E</given-names></name></person-group><article-title>Delays in Breast Cancer Detection and Treatment in Developing Countries</article-title><source><italic toggle="yes">Breast Cancer (Auckl</italic>)</source><year>2018</year><volume>12</volume><elocation-id>1178223417752677</elocation-id><pub-id pub-id-type="doi">10.1177/1178223417752677</pub-id><pub-id pub-id-type="pmid">29434475</pub-id><pub-id pub-id-type="pmcid">PMC5802601</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Molini&#233;</surname><given-names>F</given-names></name><name name-style="western"><surname>Leux</surname><given-names>C</given-names></name><name name-style="western"><surname>Delafosse</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Waiting time disparities in breast cancer diagnosis and treatment: a population-based study in France</article-title><source>Breast</source><year>2013</year><volume>22</volume><fpage>810</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.breast.2013.02.009</pub-id><pub-id pub-id-type="pmid">23473773</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>LC</given-names></name><name name-style="western"><surname>Royalty</surname><given-names>J</given-names></name><name name-style="western"><surname>Howe</surname><given-names>W</given-names></name><etal>et al</etal></person-group><article-title>Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005</article-title><source>Am J Public Health</source><year>2010</year><volume>100</volume><fpage>1769</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.2105/AJPH.2009.160184</pub-id><pub-id pub-id-type="pmid">20019308</pub-id><pub-id pub-id-type="pmcid">PMC2920986</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allgar</surname><given-names>VL</given-names></name><name name-style="western"><surname>Neal</surname><given-names>RD</given-names></name></person-group><article-title>Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer</article-title><source>Br J Cancer</source><year>2005</year><volume>92</volume><fpage>1959</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6602587</pub-id><pub-id pub-id-type="pmid">15870714</pub-id><pub-id pub-id-type="pmcid">PMC2361797</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arndt</surname><given-names>V</given-names></name><name name-style="western"><surname>St&#252;rmer</surname><given-names>T</given-names></name><name name-style="western"><surname>Stegmaier</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Provider delay among patients with breast cancer in Germany: a population-based study</article-title><source>J Clin Oncol</source><year>2003</year><volume>21</volume><fpage>1440</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1200/JCO.2003.08.071</pub-id><pub-id pub-id-type="pmid">12697864</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barros</surname><given-names>&#194;F</given-names></name><name name-style="western"><surname>Uemura</surname><given-names>G</given-names></name><name name-style="western"><surname>de Macedo</surname><given-names>JLS</given-names></name></person-group><article-title>Interval for access to treatment for breast cancer in the Federal District, Brazil</article-title><source>Rev Bras Ginecol Obstet</source><year>2013</year><volume>35</volume><fpage>458</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1590/s0100-72032013001000006</pub-id><pub-id pub-id-type="pmid">24337058</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pi&#241;eros</surname><given-names>M</given-names></name><name name-style="western"><surname>S&#225;nchez</surname><given-names>R</given-names></name><name name-style="western"><surname>Perry</surname><given-names>F</given-names></name><etal>et al</etal></person-group><article-title>Delay for diagnosis and treatment of breast cancer in Bogot&#225;, Colombia</article-title><source>Salud Publica Mex</source><year>2011</year><volume>53</volume><fpage>478</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">22282140</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unger-Salda&#241;a</surname><given-names>K</given-names></name><name name-style="western"><surname>Miranda</surname><given-names>A</given-names></name><name name-style="western"><surname>Zarco-Espinosa</surname><given-names>G</given-names></name><etal>et al</etal></person-group><article-title>Health system delay and its effect on clinical stage of breast cancer: Multicenter study</article-title><source>Cancer</source><year>2015</year><volume>121</volume><fpage>2198</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1002/cncr.29331</pub-id><pub-id pub-id-type="pmid">25809536</pub-id><pub-id pub-id-type="pmcid">PMC6681165</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Norsa&#8217;adah</surname><given-names>B</given-names></name><name name-style="western"><surname>Rampal</surname><given-names>KG</given-names></name><name name-style="western"><surname>Rahmah</surname><given-names>MA</given-names></name><etal>et al</etal></person-group><article-title>Diagnosis delay of breast cancer and its associated factors in Malaysian women</article-title><source>BMC Cancer</source><year>2011</year><volume>11</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/1471-2407-11-141</pub-id><pub-id pub-id-type="pmid">21496310</pub-id><pub-id pub-id-type="pmcid">PMC3101177</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>An</surname><given-names>J</given-names></name><name name-style="western"><surname>Hershberger</surname><given-names>PE</given-names></name><name name-style="western"><surname>Ferrans</surname><given-names>CE</given-names></name></person-group><article-title>Delayed Presentation, Diagnosis, and Treatment of Breast Cancer Among Chinese Women: An Integrative Literature Review</article-title><source><italic toggle="yes">Cancer Nurs</italic></source><year>2023</year><volume>46</volume><fpage>217</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1097/NCC.0000000000001074</pub-id><pub-id pub-id-type="pmid">35283469</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walter</surname><given-names>F</given-names></name><name name-style="western"><surname>Webster</surname><given-names>A</given-names></name><name name-style="western"><surname>Scott</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>The Andersen Model of Total Patient Delay: A Systematic Review of Its Application in Cancer Diagnosis</article-title><source><italic toggle="yes">J Health Serv Res Policy</italic></source><year>2012</year><volume>17</volume><fpage>110</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1258/jhsrp.2011.010113</pub-id><pub-id pub-id-type="pmid">22008712</pub-id><pub-id pub-id-type="pmcid">PMC3336942</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weller</surname><given-names>D</given-names></name><name name-style="western"><surname>Vedsted</surname><given-names>P</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>G</given-names></name><etal>et al</etal></person-group><article-title>The Aarhus statement: improving design and reporting of studies on early cancer diagnosis</article-title><source>Br J Cancer</source><year>2012</year><volume>106</volume><fpage>1262</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/bjc.2012.68</pub-id><pub-id pub-id-type="pmid">22415239</pub-id><pub-id pub-id-type="pmcid">PMC3314787</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Afaya</surname><given-names>A</given-names></name><name name-style="western"><surname>Anaba</surname><given-names>EA</given-names></name><name name-style="western"><surname>Bam</surname><given-names>V</given-names></name><etal>et al</etal></person-group><article-title>Socio-cultural beliefs and perceptions influencing diagnosis and treatment of breast cancer among women in Ghana: a systematic review</article-title><source>BMC Womens Health</source><year>2024</year><volume>24</volume><elocation-id>288</elocation-id><pub-id pub-id-type="doi">10.1186/s12905-024-03106-y</pub-id><pub-id pub-id-type="pmid">38745160</pub-id><pub-id pub-id-type="pmcid">PMC11092234</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>P</given-names></name></person-group><article-title>The concept of diseases and health care in African traditional religion in Ghana</article-title><source>HTS Theological Studies</source><year>2015</year><volume>71</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.4102/hts.v71i3.2762</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salisu</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Mirlashari</surname><given-names>J</given-names></name><name name-style="western"><surname>Seylani</surname><given-names>K</given-names></name><etal>et al</etal></person-group><article-title>Fatalism, distrust, and breast cancer treatment refusal in Ghana</article-title><source>Can Oncol Nurs J</source><year>2022</year><volume>32</volume><fpage>198</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.5737/23688076322198205</pub-id><pub-id pub-id-type="pmid">35582248</pub-id><pub-id pub-id-type="pmcid">PMC9040785</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohd Mujar</surname><given-names>NM</given-names></name><name name-style="western"><surname>Dahlui</surname><given-names>M</given-names></name><name name-style="western"><surname>Emran</surname><given-names>NA</given-names></name><etal>et al</etal></person-group><article-title>Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><elocation-id>e0176394</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0176394</pub-id><pub-id pub-id-type="pmid">28448541</pub-id><pub-id pub-id-type="pmcid">PMC5407802</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohd Mujar</surname><given-names>NM</given-names></name><name name-style="western"><surname>Dahlui</surname><given-names>M</given-names></name><name name-style="western"><surname>Emran</surname><given-names>NA</given-names></name><etal>et al</etal></person-group><article-title>Breast Cancer Care Timeliness Framework: A Quality Framework for Cancer Control</article-title><source><italic toggle="yes">JCO Glob Oncol</italic></source><year>2022</year><volume>8</volume><elocation-id>e2100250</elocation-id><pub-id pub-id-type="doi">10.1200/GO.21.00250</pub-id><pub-id pub-id-type="pmid">35286134</pub-id><pub-id pub-id-type="pmcid">PMC8932493</pub-id></element-citation></ref></ref-list><sec sec-type="data-availability"><title>Data availability statement</title><p>All data relevant to the study are included in the article or uploaded as supplementary information.</p></sec></back><sub-article id="sub-article1" article-type="aggregated-review-documents"><front-stub><title-group><article-title>Review Process File</article-title></title-group><pub-date pub-type="epub"><day>31</day><month>08</month><year>2025</year></pub-date></front-stub><body><fig id="d67e4887" position="anchor" orientation="portrait"><media xlink:href="bmjopen-2024-098087.reviewer_comments.pdf" position="float" orientation="portrait"/></fig></body></sub-article></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>